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Abstract 
 
In contrast to peptides, oligonucleotides, and increasingly oligosacharides, which 
can be rapidly and flexibly assembled in a systematic fashion from pre-fabricated 
building blocks, the synthesis of small molecules has remained a relatively slow, 
complex, and unsystematized process. With the potential of addressing these limitations, 
an analogous building block-based approach for making small molecules has been 
proposed in our group. In the idealized limit, a collection of off-the-shelf boronic acid-
based building blocks having all of the required functional groups pre-installed in the 
correct oxidation states and with the desired stereochemical relationships are readily 
assembled using only a single cross-coupling reaction repeatedly.  
Such an iterative cross-coupling (ICC) strategy has been applied in our proposed 
total synthesis of clinically valuable polyene natural product amphotericin B (AmB). In 
our retrosynthetic analysis, AmB is disconnected into four bifunctional building blocks 
and these building blocks are assembled via an iterative deprotection/cross-coupling 
fashion. Boronic acid-based cross-coupling reactions (Suzuki-Miyaura reaction) are 
most commonly executed to form Csp2-Csp2 bond. In practice, due to the lack of 
consecutive Csp2 centers on C1-C19 AmB skeleton, Csp3-Csp2 cross-coupling is required 
to assemble the polyol subunit BB1.  
Abstract  iii 
The synthesis of BB1 turned out to be challenging. Moreover, a Csp3-Csp2 cross-
coupling reaction was not readily available for the connection of BB1 and the rest of the 
molecule. Three generations of syntheses were developed and finally we reached a 
modular and efficient solution of the synthesis and assembly of BB1. Our total synthesis 
of the doubly-C13 labeled protected AmB is a good example to showcase the power of 
the ICC approach to small molecule synthesis.  Also from the synthesis, it is clear that 
building block scopes for ICC are currently restricted to primarily Csp2 organoborons.  
Unactivated Csp3 organoborons are often unstable and methods to access these 
building blocks are limited. In addition, at present, unactivated Csp3 organoborons 
cannot be cross-coupled with the same levels of efficiency that is now accessible with 
many of their Csp2 and activated Csp3 hybridized counterparts. In order to address these 
challenges, in my thesis research, I developed three novel methods to make Csp3 
organo-N-methyliminodiacetic acid (MIDA) boronate building blocks that are 
indefinitely bench-top stable. Additionally, inspired by our ongoing total synthesis of 
AmB, I discovered a solution to the long-standing problem of site-, and stereoretentive 
cross-coupling of unactivated secondary Csp3 boronic acids.  
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Chapter 1 
  
Introduction   
 
Organic synthesis is considered by many a form of art.1 Indeed, target oriented 
total synthesis requires exquisite design based on established reactions and more often, 
the invention of new methodologies to close the gap from the unknown. For the past few 
years, I have had the opportunity to work with my colleagues on the synthesis of the 
interesting structurally-complex, biologically-active polyene macrolide natural product 
amphotericin B (AmB).  
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The thesis is structured into two parts. In chapters 2 to 4, I will discuss our efforts 
towards an iterative cross-coupling (ICC) based strategy2 for the total synthesis of 
polyene macrolide natural product AmB. In particular, I will focus on my synthesis of 
the C1-C12 building block (BB1) and a series of attempts to couple this building block to 
the C13-C23 bifunctional building block (BB2) that was synthesized by my colleagues. 
To establish the coupling between BB1 and BB2 required a primary Csp3 organoboron-
based cross-coupling reaction that turned out to be very challenging. I went through 
three generations of synthesis to finally reach an efficient route to establish the C1-C23 
skeleton of AmB.  
 
The experience encouraged us to search for a general solution to cross-couple 
both primary and secondary Csp3 boronic. Such a methodology would greatly expand 
the power of the ICC strategy in small molecule synthesis. Building on methods of 
primary boronic acid cross-coupling that is described in chapter 3, I will discuss my 
discovery of a stereoretentive cross-coupling of unactivated secondary Csp3 boronic 
acids in chapter 5.  
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1.1  An introduction to the biology and chemistry of  
  amphotericin B (AmB)  
1.1.1  Invasive fungal infections and polyene macrolides   
The incident of systemic fungal infections has continued to rise over the past 
three decades. The infectious diseases can be life threatening particularly to patients 
with compromised immune systems.3 From 1979 to 2000, the annual number of cases 
of sepsis caused by fungal organisms increased by an astonishing 207%. 4  In fact, 
infections stemming from the pathogenic yeast Candida albicans represent the fourth 
most common cause of hospital-acquired bloodstream infections, and the mortality rate 
for these infections is 40%.5 Battling this lethal disease has cost the healthcare system a 
heavy economic burden. In 1998 alone, the United States spent $2.6 billion on treating 
systemic fungal infections.6 In addition, the occurrence of mycoses may be significantly 
underestimated due to the difficulties to diagnose fungal pathogens, resulting in a high 
ratio of false negative results for fungal blood cultures. 7  Finally, challenges from 
microbial resistance have become increasingly common that development of safe and 
effective antifungal therapies is constantly needed.  
Table 1.1. Estimated world incidence and mortality rates of some systemic fungal 
infections. Data from the Fungal Research Trust, How common are fungal diseases? 
Fungal Research Trust 20th Anniversary Meeting. June 18th 2011. 
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Currently, the last line of defense in treating invasive fungal infection is a family 
of antimicrobial agents known as the polyene macrolides.8 To date, over 200 members 
of this class of natural products have been reported, and the structures of 36 of which 
have been elucidated. Members in this class of natural products contain 1. a polyene 
subunit with either 4, 5 or 7 olefins appended with an aliphatic tail; 2. a mycosamine 
containing subunit that is generally conserved; 3. a polyol subunit with diverse 
structural configurations. The polyol subunit is often what differs between members in 
the family, therefore represents an interesting handle for functional studies and a key 
challenge for synthetic access.9  
 
Figure 1.1. AmB, an archetypical example of polyene macrolide.  
 
Isolated by Gold and coworkers in 1955 from a strain of Streptomyces nodosus 
on soil collected in the Orinoco River region of Venezuela,10 AmB is an archetypical 
example of polyene macrolide family. 11 , 12  It’s widespread importance as a clinical 
antifungal agent led to its commercialization only 3 years later.13,14 Remarkably, over the 
course of fifty years, only rare cases of microbial resistance of this drug have been 
reported.15 The discovery of AmB, as well as other members in the polyene macrolide 
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class, has significantly reduced the risk of blood-borne fungal infection from being a 
terminal disease prior to 1950.13  
On the other hand, clinical application of polyene macrolides has been plagued 
with their excessive toxicities. Similarly, severe side effects including cardio and renal 
toxicity as well as hemolytic anemia are commonly accompanied with the 
administration of AmB. 16 , 17  For instance, in a study comparing AmB to another 
antifungal agent caspofungin for treating invasive candidiasis, proportions of patients 
experienced significantly increased nephrotoxic effects and/or hypokalemia in the AmB 
group than the caspofungin group. 18  Due to extensive toxicity, sometimes 
discontinuation of AmB therapy is required despite a life-threatening systemic fungal 
infection. In order to improve the therapeutic index of this drug, liposomal formulations 
have been introduced19 and many studies have been devoted to target less toxic AmB 
derivatives from chemical modifications of the natural product.16 However, these efforts 
are crippled by a lack of understanding of the mechanism of action of AmB as well as 
other polyene macrolides.  
 
1.1.2  Classic “barrel-stave” channel formation model of  
  amphotericin B’s mechanism of action  
For the past fifty years, the leading model of AmB’s mechanism of action involves 
binding to the fungal cell membrane component, ergosterol, followed by self-assembly 
into an octomeric ion-permeable channel.20 , 21 , 22  In this way, these channels cause 
depolarization of the membrane therefore disrupting the transmembrane 
electrochemical gradient and causing cell death. 21,23  
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Figure 1.2. (A) The barrel stave model for AmB with the polyol pointing in to form a 
hydrophilic pore and the polyene pointing out towards the hydrophobic lipid bilayer. (B) 
The proposed C41 carboxylate/C3’ amine salt bridge and C8 alcohol/C9 alcohol 
hydrogen bonding interaction. (C) The tail-to-tail dimer of AmB pores stabilized by C35 
hydroxyl group hydrogen bonding. 
Adapted with permission from Palacios, D.S.; Anderson, T.M.; Burke, M.D. J. Am. Chem. 
Soc. 2007, 129, 13804-13805. Copyright 2007 American Chemical Society. 
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In this postulated mode of action, AmB molecules assemble through the 
stabilization of a salt bridge between the C41 carboxylate and the C3’ amine of 
neighboring AmB molecules, as well as a hydrogen bond between the C8 and C9 
hydroxyls of neighboring AmB molecules to form an ion channel with an interior 
diameter of approximately 8 Å.20,24,25 Additionally, AmB molecules are aligned in such a 
way that the hydrophobic polyene units are in contact with the hydrophobic chains of 
the phospholipids while the hydrophilic polyol units line the water-filled interior of the 
pore. 26,27 Despite the existence of this model for over 35 years, experimental data 
supporting this hypothesis is scarce.20,25 Evidence regarding the binding interaction is 
largely based on computational studies28 and the exact nature of this self-assembled 
complex is still poorly understood.   
This mechanism of action by binding to sterols and self-assembly into an ion 
channel complex puts AmB outside the modern paradigm of pharmacology which 
operates via the inhibition of protein targets. This hypothesis has been explored to 
explain AmB’s low microbial resistance that has been observed.  
AmB29 and all other polyene macrolides30,31 are produced by a common modular 
type I polyketide synthase (PKS) machinery found in their respective producing 
organisms. For AmB, C19 Mycosamine, C41 carboxylate and C8 hydroxyl are installed 
after the construction of the macrolide by tailoring enzyme modifications.27 
Interestingly, all three functional groups have been proposed to be critical in stabilizing 
the AmB ion channels. Therefore, access to AmB derivatives with lacking each of these 
post-PKS installed functional groups may pave the way to probe the “barrel-stove” 
mechanism of AmB.  
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Scheme 1.1. Tailoring enzyme modifications in AmB’s biosynthetic pathway.  
 
1.1.3  Sterol binding model of AmB’s mechanism of action  
Our laboratory proposed that AmB’s primary mode of action is alternatively 
simply sterol binding, while ion channel formation only serves as a complementary 
mode of action thus enhancing its antimycotic activity. To test the hypothesis our group 
applies the strategy that was described in previous section, and targeted and synthesized 
a series of AmB derivatives lacking functional groups that have been hypothesized to be 
important for channel formation.32  
Presented in Figure 1.3, synthesis of amphoteronolide (AmdeB) and C41 
decarboxylate AmB (C41MeAmB) was accomplished by my colleagues Palacios and 
Anderson.33 Synthesis of C35 deoxy AmB (C35deOAmB) was executed by a team lead by 
Gray and Palacios.34 Surprisingly, studies on these derivatives have revealed that while 
mycosamine and C35 hydroxy are indispensable to form channels, C41 carboxylate only 
plays a minor, if any role in such a mechanism. Furthermore, although channel 
formation was not observed for C35deOAmB, it still retained antifungal activity. 
Collectively, biophysical and biological studies of these and other derivatives have led to 
the conclusion that sterol binding is the primary mechanism of action of AmB. Guided 
by these findings, C2’ deoxy derivative of AmB (C2'deOAmB) was synthesized by my 
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colleagues Wilcock, Endo and Uno and was examined to have an improved therapeutic 
index.35  
                                               
AmB  AmdeB  C41MeAmB C35deOAmB  C2'deOAmB  
S. cerevisiae MIC 0.5 >500  0.5 3 1 
C. albicans MIC 0.25 >500  0.25 4 1 
human red blood 
cells MHC  8.5 >500  No data  No data  >500  
human renal 
epithelial cells MTC  2.4 >80  No data  No data  >80  
ion channel 
formation capacity Yes  No  Yes  No  No data  
 
Figure 1.3. Biological studies of AmB and AmB derivatives. Units for MIC, MHC and 
MTC are in μM.  
 
Access to functional group deficient AmB derivatives has been pivotal in our 
understanding of AmB. However, the synthetic overhead has been the rate-limiting step 
towards further studies of AmB. Meanwhile, the current derivatives were synthesized 
from a top-down or hybrid approach that the natural product was used as the starting 
material. Preparation of most other AmB derivatives such as the C8 deoxy AmB 
(C8deOAmB) or C13 labeled derivative for both mechanistic and pharmacological studies 
can only stem from a modular total synthesis of AmB.  
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1.2   An iterative cross-coupling (ICC) strategy for  
  small molecule synthesis  
Organic synthesis has played an important role in modern drug discovery by 
allowing access to small molecules with functional properties. For instance, 91% of small 
molecule new chemical entities (NCE) discovered from 1981-2006 are synthesized 
natural products or natural products derivatives. 36  More recently, development of 
molecular targets based high-throughput screens had led to an increasing demand for 
the generation of large libraries of derivatives by modification of active natural product 
skeletons as leads.37  
However, the remarkable complexity and variety of molecular structures found in 
nature made small molecule synthesis a relatively complex, unsystematized, and labor-
intensive process.  To date, target-oriented synthesis still represents the bottleneck in 
the efforts to study, understand, and harness the vast functional capacity of small 
molecules.  
In contrast, many peptides,38 oligosaccharides,39 and oligonucleotides40 can now 
be readily prepared via general and automated synthesis platforms. In these systems 
common sets of building blocks, having all of the required functional groups pre-
installed in the correct oxidation states and with the desired stereochemical 
relationships are assembled via the recursive application of a single reaction. The 
development of these modular synthesis platforms has dramatically increased the 
throughput with which these compounds can be prepared. As a result, the rate-limiting 
step in these areas has shifted from synthesis to the study of structure-function 
relationships, which in turn has had a transformational impact on many areas of science, 
medicine, and technology.  
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Scheme 1.2. Synthesis of complex molecules from simple building blocks. (A) Iterative 
amide bond formation to synthesize peptides from protected amino acids. (B) Iterative 
Suzuki Miyaura cross-coupling to synthesize small molecules from bifunctional halo-
MIDA boronates.  
 
Inspired by the automated synthesis platforms, our group has been pursuing a 
more systematized approach towards complex small molecule construction, e.g. a 
synthesis strategy based upon the concept of iterative cross-coupling (ICC).41 In this 
platform, complex small molecules are assembled from bifunctional boron-protected 
haloboronic acid building blocks via the recursive application of the Suzuki-Miyaura 
cross-coupling reaction. This strategy is enabled by a protecting group for boronic acids 
known as N-methyliminodiacetic acid (MIDA) that was discovered in group in 2007.42  
Complexing a boronic acid with MIDA rehybridizes the boron center from sp2 to 
sp3 and thereby removes its p-orbital, which renders the resulting boron center inert to 
Suzuki-Miyaura cross-coupling conditions, thus allowing a chemoselective cross-
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coupling with another boronic acid or other reactive boronic ester. On the other hand, 
MIDA boronates can be deprotected with mild aqueous base to give free boronic acids or 
transligated to boronic esters, both of which can then undergo subsequent cross-
coupling with another bifunctional building block and thereby iterate the C-C bond 
formation process. Applying this strategy, a number of polyaryl and polyene natural 
products including ratanhine,42 retinal,43 parinaric acid,43 crocacin C,43 peridinin,44 and 
synechoxanthin,45 have been synthesized in our group.  
Highlighting the ICC strategy is the synthesis of C35deOAmB 1.5 presented in 
Scheme 1.3,34,43 which took advantage of the modular nature of this approach and 
established the key framework to target other AmB derivatives. Starting from the C1-
C23 building block 1.7, which was prepared from an ozonolysis-based degradation 
sequence of AmB, deprotection of MIDA boronate was followed by the chemoselective 
cross-linked with bifunctional halo MIDA boronate 1.8. The deprotection/cross-
coupling sequence was repeated with dienyl iodide 1.9 to afford the all carbon skeleton 
of C35deOAmB.  
Despite the success, it is evident that the synthesis of building block 1.7 was 
originated from the degradation of the natural product, therefore making 
functionalization of C1-C23 challenging. In order to access functional group deficient 
and/or C13 labeled derivatives from C1-C23, development of an AmB total synthesis 
including a bottom-up synthesis of C1-C23 building block in the ICC platform is needed. 
However, expanding the ICC strategy to the synthesis of molecules beyond those 
possessing many Csp2-Csp2 connections is at present challenging. This is attributed to 
the challenges associated with Csp3 based cross-couplings with either alkyl boronic acids 
or alkyl halides.  
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Scheme 1.3. An ICC-based retrosynthetic strategy to the synthesis of C35deOAmB.  
 
In the case of Csp3 boronic acid, the major challenges are: 1. much lower 
reactivity during both transmetallation and reductive elimination of Csp3 boronic acids 
compared to their Csp2 counterparts; 2. various potential side reactions as a result of 
competitive β-hydride elimination. Furthermore, in the case of cross-coupling of 
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unactivated chiral secondary Csp3 boronic acids, the absolute stereochemistry of the 
products is unknown. Therefore, establishment of a facile method for cross-coupling of 
Csp3 organoboron building blocks is critical in our proposed total synthesis of AmB. In 
addition, successful development of such methodology stands to substantially expand 
the scope of the ICC platform by offering Csp3-Csp2 disconnections.      
 
1.3   Synthesis of the C1-C23 and the total synthesis  
  of amphotericin B  
To date, the only accomplished total synthesis of AmB was reported by Nicolaou 
in the late 1980s. 46  Nicolaou’s retrosynthesis begins with the disconnection of the 
mycosamine to get back to amphoteronolide 1.10 (Scheme 1.4). The aglycone was 
further disconnected into two equal-sized building blocks 1.11 and 1.12 via an 
esterification and a ring-closing Horner-Wadsworth-Emmons reaction. Polyenone 1.11 
was synthesized from another Horner-Wadsworth-Emmons reaction between aldehyde 
1.13 and phosphonate 1.14, while C1-C20 Building block 1.12 was assembled from 1.15, 
1.16 and 1.17. One of the highlights in this synthesis is that both building blocks 1.13 
and 1.17 were prepared from (+)-diethyltartrate applying similar chemistry. 
Nonetheless, the Nicolaou synthesis required over 120 total steps and 58 steps in the 
longest linear sequence. The length of this synthesis makes access of many derivatives of 
interest impractical. A more efficient and modular total synthesis of AmB is needed and 
we propose this can now be achieved via the ICC platform.  
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Scheme 1.4. Nicolaou’s retrosynthesis of AmB 1.1.  
 
The goal for our total synthesis of AmB is to establish a modular route to target 
any derivative of interest by simply preparing and assembling modified building blocks. 
Building on the C35deOAmB synthesis that was developed in our group, we propose a 
retrosynthetic strategy by disconnecting into 4 bifunctional building blocks. In the 
forward direction, these building blocks will be stitched together iteratively via only 
Suzuki-Miyaura cross-coupling. One of the key challenges in this proposal is the Csp3 
organoboron cross-coupling between 1.19 and 1.20. Our approaches, discoveries and a 
final solution to address this problem will be discussed in this thesis.  
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Scheme 1.5. ICC-based retrosynthetic strategy to the synthesis of AmB.  
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Chapter 2  
 
First generation synthesis of 
amphotericin B polyol subunit BB1  
 
AmB is a polyene natural product with remarkable pharmacological activity; 
however it’s toxicity to humans has stymied its efficacy. Since the 1980s, more than a 
dozen synthetic groups including Masamune,1, 2 Nicolaou,3, 4 McGarvey,5 Carreira6, 7 and 
Solladié8, 9 have worked on the total synthesis of this natural product. Nevertheless, to 
date, the only accomplished total synthesis of this molecule was reported by Nicolaou 
and coworkers in a series of publications in late 1980s.3, 4 To summarize the challenges 
of this synthesis, Carreira states in a 2006 review on the chemistry of AmB: “In 
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reviewing the state of the art in macrolide synthesis in those years, both Masamune and 
Nicolaou noted two major problems: 1. formation of the macrocyclic ring; and 2. 
assembly of the polyol subunits.”10 This quote is supported by a great deal of interest in 
the synthesis of the AmB polyol subunits received from the synthetic community. 
Indeed, synthesis and manipulation of the stereochemically-congested C1-C12 polyol 
building block of AmB has been reported by over 10 research groups and has produced 
enduring and widely applicable synthetic methodologies in the areas of enantio- and 
diastereoselective polyol synthesis and carbon-carbon bond formation.  
 
Figure 2.1 Further disconnection of AmB polyol building block is at either C6-C7, 
including Masamune,1 Kinoshita,11 Nicolaou12 and Furstner,13 or at C7-C8, including 
Hanessian,14 Carreira,15 Solladie,9 Fraser-Reid,16 McGarvey,5 Bonini17 and Cossy. 18 
 
The synthesis of this building block involves multiple C-C bond formation 
reactions from simpler starting materials. Most reported syntheses in the literature 
employ a further disconnection at either C6-C7 or C7-C8 to give two roughly equal sized 
building blocks. This is a strategy we also adopted in our synthesis of this fragment. 
Among these existing syntheses, our final synthesis has the fewest steps and highest 
overall yield. 
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2.1 Reported synthesis of amphotericin B polyol 
subunit in the literature  
One of the earliest efforts to tackle the total synthesis of AmB was reported by 
Masamune and coworkers (Scheme 2.1).19 In his synthesis of the polyol subunit, C1-C6 
fragment 2.2 and C7-C12 fragment 2.3 were prepared from a common 
enantiomerically-enriched epoxide 2.1. Lithiation of C7-C12 sulfoxide 2.3 followed by 
alkylation afforded the C1-C12 framework 2.4 in a relatively low 30% yield. This 
intermediate was then converted to triflate 2.5 and coupled with lithiated sulfone 
building block 2.6 to yield C1-C19 subunit in 92% yield. 20  
Just to highlight one of the many interesting challenges in this synthesis of AmB 
is that if the stereochemistry of the carbon labeled with blue on the orthoester 2.6 is 
inverted, no product for this coupling was observed. Post coupling modification arrived 
phosphate 2.8 which was then subjected a two-step sequence consisted with 
esterification and macro Horner-Wadsworth-Emmons cyclization to furnish the 
aglycone 2.10.  
One of the drawbacks of this classic synthesis is that 17 steps are required after 
the coupling of 2.5 and 2.6. The linearity of this route makes targeting AmB derivative 
via building block modification inefficient. A similar macrocyclic ring-closing strategy is 
used in both Nicolaou’s total synthesis of AmB and Carreira’s synthesis of the C35 
deoxy- methyl ester AmB derivative 2.17.  
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Scheme 2.1. Masamune’s synthesis and coupling of AmB polyol subunit.  
 
Carreira developed a more efficient second generation synthesis of this building 
block that involves a novel chelate-based diastereoselective alkynylation to tie the C7-C8 
bond and afforded 2.13 in excellent yield and good d.r..15,21 After a few steps of 
functional group manipulation, a nitrile oxide 1,3-dipolar cycloaddition prepared the C1-
C19 intermediate 2.16 in excellent yield. Thereafter, 7 more steps would give the 
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Masamune phosphate 2.8, en route to the doubly modified AmB derivative 2.17 
(Scheme 2.2).  
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Scheme 2.2. Carreira’s synthesis and cross-coupling of AmB polyol subunit.  
 
The examples described above demonstrate the two general schemes of AmB 
polyol subunit synthesis: 1. alkylation or olefination between C6-C7 such as the 
Masamune synthesis; 2. nucleophilic attack to C8 aldehyde to form C7-C8 bond as 
represented by the Carreira synthesis. Another approach, which was reported by 
BouzBouz and Cossy took advantage of a new method for the formation of syn-1,3,-diol 
from β-hydroxy aldehydes that was developed in the Cossy  group (Scheme 2.3).18 Key 
steps in their synthesis of the AmB C1-C14 polyol fragment 2.23 are an interesting 
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enantioselective allyltitanation reaction that was applied twice with allylating reagents 
of the opposite enantiomeric configurations ((R,R)-2.19 and (S,S)-2.19) and yielded 
products with corresponding desired stereo-configurations. Despite being an interesting 
approach, no reports of the synthesis being taken forward to furnish the natural product 
or close derivatives are published to date.  
 
Scheme 2.3. BouzBouz and Cossy’s synthesis of AmB polyol subunit.  
 
The three examples for synthesis of this intriguing building block discussed here 
are a representation of over ten syntheses.10 Our route to the polyol subunit of AmB, 
which will be discussed in the next three chapters, is in fact the shortest and highest 
overall yielding one. In addition, our building block is uniquely applicable to the ICC 
platform, making practical synthesis of many AmB derivatives accessible.  
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2.2 Development of a novel one-pot diastereo-
selective hydroboration/cross-coupling strategy  
Our ICC-based strategy for the synthesis of AmB involves initial retrosynthetic 
fragmentation of the Csp2-rich polyene motif to generate building blocks BB3 (2.26), 
BB4 (2.27) and a C1-C23 containing intermediate 2.25. We have previously 
demonstrated that derivatives of intermediate 2.25, differing only in the identity of 
some protective groups, can be transformed via ICC to both AmB22 and C35-
deoxyAmB.23  
Depicted in Scheme 2.4, to further disconnect the C1-C21 region of this natural 
product, we considered the fragmentation of 2.25 at the C12-C13 bond into Csp3 alkyl 
borane BB1 (2.28) and Csp2 cyclic ketene acetal phosphate BB2 (2.29). Importantly, 
the C11-C17 motif is strictly conserved in every known mycosamine-bearing polyene 
macrolide natural product.24,25 Hence, the successful development of such a cross-
coupling would help enable the ICC based synthesis of any member of this family. Thus, 
once developed, such a method could be widely applicable to the cross-coupling based 
synthesis of many other natural products and/or their derivatives. 
Realizing this potential solution required three important developments: 1. a 
method for the diastereoselective synthesis of the unprecedented C9-C12 motif of BB1: 
an alkylborane flanked by a stereodefined 1,3-diol motif at the beta-delta carbons, 2. an 
efficient, stereo-controlled, and scalable route to BB1, 3. cross-coupling the Csp3 borane 
terminus of BB1 with a ketene acetal phosphate BB2 under conditions compatible with 
MIDA boronates.  
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Scheme 2.4. ICC-based retrosynthesis of AmB.  
 
We first targeted a method for preparing the C8-C12 motif of BB1 in a stereo-
controlled fashion. Specifically, inspired by Leighton’s diastereoselective 
hyrdorhodation of methylene 1,3-dioxanes,26 we proposed an analogous substrate-
controlled diastereoselective hydroboration to synthesize BB1 stereoselectively. In 
Leighton’s model, a half-chair ground state of 2.30 prior to the hydrorhodation was 
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proposed. Re face approach of rhodium-hydride via a favorable chair-like transition 
state leads to the syn-1,3-dioxane 2.32; while the anti-1,3-dioxane product requires a Si 
face attack via a high energy twist-boat like transition state (Scheme 2.5).  
 
 
Scheme 2.5. Leighton's model for diastereoselective hydrorhodation.  
 
Scheme 2.6. Synthesis of a BB1 model substrate.  
 
To validate the stereo-outcome of the hydroboration followed by the resulting 
cross-coupling primary Csp3 borane BB1, a model study was performed. The route to 
prepare BB1 analog 2.37 is summarized in Scheme 2.6. Starting from known mono 
TBS protected ethylene glycol 2.33, Swern oxidation followed by Grignard addition gave 
homoallylic alcohol 2.34 in 82% yield over 2 steps. Dimethyldioxirane oxidation of the 
resulting olefin afforded epoxide 2.35 in 50% yield (83% based on recovery of starting 
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material). The epoxide was then opened by LiBr. Subsequent ketalization and 
elimination yielded methylene 1,3-dioxane 2.37 (Scheme 2.6). 
With this intermediate in hand, hydroboration with 9-BBN proceeded very 
smoothly to generate alkyl borane intermediate 2.38. After oxidative work-up, the 
resulting protected tetraol 2.3927-29 was isolated in 57% yield, the diastereoselectivity 
was confirmed via the Rychnovsky method (Scheme 2.7). Encouraged by this result, 
we then moved on to the synthesis of BB1. 
 
Scheme 2.7. Study of the stereo-outcome of the hydroboration.  
 
2.3  Unsuccessful synthesis of BB1 based on a cross-
metathesis strategy  
In our first attempted synthesis, we envisioned an olefin metathesis strategy to 
further dissect BB1 into two easily accessible building blocks. Guided by Grubbs’ general 
model for selectivity in olefin cross metathesis,30 we anticipated a high selectivity of 
cross metathesis (over homo metathesis) between type III olefin 2.41 and type II olefin 
2.42.  
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Scheme 2.8. Further disconnection via olefin cross-metathesis.  
 
Conveniently, building block 2.41 can be prepared in 1 step from known 
compound 2.44,31, 32 which was synthesized in 5 steps in non-racemic form from 
commercial starting material (Scheme 2.9). The proposed synthesis of 2.42 is 
depicted in Scheme 2.10. Starting with 4-pentenoic acid, loading with Evan’s auxiliary 
is followed by oxygenation to set up the stereocenter at C9. Amide formation, silylation 
and vinylation afforded diene 2.48. Site selective epoxidation, ring opening and 
desilylation yielded diol intermediate 2.49 that is 1 step away from 2.42. However, 
attempts to ketalize diol 2.49 were hampered by competing intramolecular cyclization 
as evidenced by a fast conversion to the tricyclic byproduct 2.51. A thorough screen of 
Lewis acid catalysts and ketalization reagents were carried out but turned out to be 
fruitless (Scheme 2.10).  
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Scheme 2.9. Synthesis of type III olefin 2.41.  
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Scheme 2.10. Attempted synthesis of olefin 2.42.  
 
Since it is evident that ketalization in the presence of C8 carbonyl is difficult, we 
revised our synthetic plan by reducing the ketone before exposing the diol to 
ketalization condition. In this vein, cross metathesis between 2,41 and benzylated 
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enone 2.53 was tested. However, a screen of Grubbs catalysts and optimization resulted 
a best yield of only 17%, making this approach impractical (Scheme 2.11).30, 33  
 
  
Scheme 2.11. Low-yielding olefin cross-metathesis to 2.54.  
 
2.4  Successful first generation synthesis of BB1 in 
the form of 9-BBN alkyl borane and challenges 
within  
In order to bypass this low-yielding cross-metathesis reaction, inspired by a 
similar strategy Nicolaou used in his synthesis, we next examined a Horner–
Wadsworth–Emmons coupling reaction to target the crucial enone intermediate. 
Aldehyde coupling partner 2.55 can be prepared in 1 step from ozonalysis of olefinic 
intermediate 2.41 (Scheme 2.12). Synthesis of phosphate coupling partner 2.58, 
which is depicted in Scheme 2.13, requires only 4 steps from readily accessible starting 
material.  
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Scheme 2.12. Synthesis of aldehyde 2.55.  
 
 
Scheme 2.13. Synthesis of phosphate 2.58.  
 
Starting from commercially available, enantiomerically-enriched (R)-malic acid, 
selective esterification followed by ketalization afforded dioxanone 2.57 in 89% yield 
over 2 steps. Site-selective vinylation and subsequent phosphonation gave forth 
coupling partner 2.58. It needs to be noted that reagent selection played an important 
role in this sequence. For instance, ketalization of intermediate 2.59 with dimethyl ketal 
2.61 proceeded with low conversion. The yield was boosted to 92% by simply switching 
to methoxy cyclopentene 2.60 (Scheme 2.14). In a second case, chemoselectivity of 
vinylation of 2.57 with the Petasis reagent improved significantly when ethyl ester was 
in place of methyl ester, as demonstrated by the increase in yield (Scheme 2.15).  
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Scheme 2.14. Reaction condition optimization for 2.59.  
 
Scheme 2.15. Reaction condition optimization for 2.57.  
 
With both coupling partners in hand, the Horner-Wadsworth-Emmons reaction 
proceeded smoothly to afford enone intermediate which was immediately subjected to 
the Stryker’s reduction to yield ketone 2.62 in 51% over two steps. Substrate controlled 
diastereoselective reduction with L-selectride followed by silylation afforded BB1 
precursor 2.63.12 The yield for the last step drops significantly on larger scale and 
ranges from 35-71% (Scheme 2.16).  
With 2.63 in hand, BB1 2.64 was prepared by diastereoselective hydroboration 
with 9-BBN, which was not isolated and subjected directly to couple with a BB2 analog 
2.65 derived valerolactone in a model study. Gratifyingly, the coupling furnished the 
desired product 2.66 under Buchwald’s anhydrous condition: a system that has been 
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tested to be compatible with other functional groups that will be present on the actual 
BB2 (Scheme 2.17).34, 35  
 
Scheme 2.16. Synthesis of BB1 precursor 2.63.  
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Scheme 2.17. Model cross-coupling of BB1-BB2.  
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Scheme 2.18. Isomerization of 2.63 to an internal olefin.  
 
Despite the success in establishing a synthesis and cross-coupling of the polyol 
subunit BB1, the low yielding and capricious nature of the silylation to furnish 2.63 and 
substantial stabilities of these intermediates has made this route difficult to scale. 
Moreover, this route lacks a stable intermediate suitable for storage which is important 
for the building block based ICC synthetic strategy. A thorough analysis of this reaction 
revealed that the observed challenge was due to the highly sensitive nature of the 
methylene dioxane moiety (labeled in blue) on 2.63 (Scheme 2.18). Isomerization to 
the internal olefin was frequently observed upon work up and/or chromatographic 
purification which yielded byproduct 2.64 that is very difficult to be separated. After 
numerous attempts, this drawback remains and makes this route impractical to target 
an efficient and modular synthesis. We thereby moved on to a second generation 
synthesis.  
 
2.5  Experimental section  
Materials.  Commercial reagents were purchased from Sigma-Aldrich, Fisher 
Scientific, Alfa Aesar, TCI America, or Frontier Scientific, and were used without further 
purification unless otherwise noted.  
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Solvents were purified via passage through packed columns as described by 
Pangborn and coworkers1 (THF, Et2O, CH3CN, CH2Cl2: dry neutral alumina; hexane, 
benzene, and toluene, dry neutral alumina and Q5 reactant; DMSO, DMF: activated 
molecular sieves). All water was deionized prior to use. Diisopropylethylamine was 
freshly distilled under an atmosphere of nitrogen from CaH2.  
 
General experimental procedures.  Unless noted, all reactions were 
performed in flame-dried round bottom or modified Schlenk flasks fitted with rubber 
septa under a positive pressure of argon or nitrogen. Organic solutions were 
concentrated via rotary evaporation under reduced pressure with a bath temperature of 
23°C unless otherwise noted. Reactions were monitored  by analytical thin layer 
chromatography (TLC) performed using the indicated solvent on E. Merck silica gel 60 
F254 plates (0.25mm).  Compounds were visualized by exposure to a UV lamp (λ = 254 
nm), and/or a solution of KMnO4 and/or a solution of p-anisaldehyde, followed by brief 
heating using a Varitemp heat gun. Column chromatography was performed using 
Merck silica gel grade 9385 60Å (230-400 mesh).  
 
Structural analysis. 1H NMR and 13C NMR spectra were recorded at 20 oC on 
Varian Unity 500, Varian Unity Inova 500NB or Varian Unity 500 instruments.  
Chemical shifts (δ) are reported in parts per million (ppm) downfield from 
tetramethylsilane and referenced to residual protium in the NMR solvent (benzene, δ = 
7.16; CHCl3, δ = 7.26; acetone, δ = 2.05, center line; DMSO δ = 2.50, center line) or to 
added tetramethylsilane (δ = 0.00).  Data are reported as follows: chemical shift, 
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multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sept = 
septet, m = multiplet, b = broad, app = apparent), coupling constant (J) in Hertz (Hz), 
and integration.  Chemical shifts (δ) for 13C NMR are reported in ppm downfield from 
tetramethylsilane and referenced to carbon resonances in the NMR solvent (benzene-d6, 
δ = 128.06, center line; CDCl3, δ = 77.0, center line; acetone-d6,  δ = 39.5, center line; 
DMSO-d6 δ = 39.52, center line). Carbons bearing boron substituents were not 
observed (quadrupolar relaxation). High resolution mass spectra (HRMS) were 
performed by Furong Sun, Dr. Steve Mullen and Dr. Haijun Yao at the University of 
Illinois School of Chemical Sciences Mass Spectrometry Laboratory.   
 
 
Epoxide 2.35. To a solution of 2.34 (1.08 g, 5 mmol) in 20 mL CH3CN and 20 
mL 0.4 mM Na2EDTA at 4 °C, was added cold 0.3 mL 1,1,1-trifluroacetone with a 
pasteur pipette. A mixture of oxone and sodium bicarbonate was then added 
portionwise over 2 h. (Oxone:Sodium bicarbonate = 15.37 g:4.3 g) The resulting white 
suspension was stirred for 5 h at 4 °C. The solids were then removed by filtration and 
washed with ether. The two layers of filtrate were separated and the organic phase was 
washed with saturated aqueous NaHCO3 and brine, then dried over MgSO4, the solvent 
was removed under reduced pressure. Flash chromatography (SiO2, hex:EtOAc = 5:1) 
yielded 0.58 g (50%) product 2.35 as a mixture of two diastereomers, with recovered 
starting material (0.43 g). Yield based on recovered starting material was 83%.  
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TLC (hex:EtOAc 5:1)  
Rf = 0.10, stained by p-anisaldehyde  
 
1H NMR (500 MHz, CDCl3) δ 3.88 (m, 1H), 3.68 (dd, J = 10, 4 Hz, 0.6H), 3.63 
(dd, J = 10, 3.5 Hz, 0.4H), 3.54 (dd, J = 10, 7 Hz, 0.4H), 3.45 (dd, J = 10, 7.5 Hz, 0.6H), 
3.12 (m, 1H), 2.82 (t, J = 4.5 Hz, 0.6H), 2.79 (t, J = 4.5 Hz, 0.4H), 2.55 (m, 1H), 1.84 (m, 
0.6H), 1.75 (m, 0.4H), 1.67 (m, 0.4H) 1.48 (m, 0.6H), 0.90 (s, 9H), 0.08 (s, 6H).  
 
HRMS (ESI+)  
Calculated for C11H24O3SiNa: 255.1392  
Found: 255.1394   
 
 
Diol 2.68. To a stirred solution of 2.35 (670 mg, 2.89 mmol) and acetic 
acid(0.82 mL, 8.66 mmol) in THF(30 mL) under argon at 23 °C was added lithium 
bromide (501 mg, 5.77 mmol). The solution was allowed to stir for 6 h and white 
precipitation was observed. Upon stopping the reaction, the solution was diluted with 
1:1 H2O: brine (30 mL) and ether (30 mL) and separated. The aqueous phase was 
extracted with 3X 50ml ether and the combined organic layers were washed with sat. 
NaHCO3 (200 mL), and dried over MgSO4. The solvent was removed in vacuo and the 
crude product 2.68 was used without further purification in the next reaction.  
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1H NMR (500MHz, CDCl3) δ 4.10 (m, 1H), 3.94 (m, 1H), 3.66-3.45 (m, 4H), 1.80-
1.58 (m, 2H), 0.90 (s, 9H), 0.08 (s, 6H)  
 
  
Ketal 2.36. To a stirred solution of crude diol 2.68 (901.9 mg, 2.89 mmol) in 
2,2-dimethoxy propane (22.74 mL, 184.96 mmol) was added PPTS (80.42 mg, 0.32 
mmol). The reaction was allowed to stir for overnight. Upon stopping the reaction, the 
mixture was diluted with 10mL 1:1 sat. aq. NH4Cl:H2O and the aqueous phase was 
extracted with 3x diethyl ether. The combined organic layer were dried over MgSO4, 
filtered and concentrated. Flash chromatography (SiO2, 5:1 = hex:EtOAc) yielded the 
desired product as a colorless oil. (878.7 mg, 90% over two steps)  
 
TLC (hex:EtOAc 5:1)  
Rf = 0.48, stained by p-anisaldehyde  
 
1H NMR (500 MHz, CDCl3) δ 4.03 (m, 1H), 3.92 (m, 1H), 3.67 (m), 3.57 (dd, J = 
10.5, 5 Hz), 3.50 (dd, J = 10.5, 6 Hz), 3.49 (m), 3.38 (m), 2.79 (dd, J = 10, 6 Hz), 3.57-
2.79 (4H) 1.83 (t, J = 2.5 Hz), 1.81 (t, J = 2.5 Hz), 1.77 (m), 1.66 (m), 1.83-1.66 (2H) 1.41 
(m, 6H), 0.89 (s, 9H), 0.06 (m, 6H).  
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Methylene dioxane 2.37. To a stirred solution of ketal 2.36 (1.01 g, 3.0 mmol) 
in toluene (6 mL) was added 1,8-diazobicyclo[5,4,0] (4.49 mL, 30 mmol), and the 
mixture was heated to 100 °C and stirred for 5 h. After cooling to 23 °C, the resulting 
solution was filtered, and the solid was washed with hexane. The ethereal layer was 
washed with water (10 mL) and dried over Na2SO4 and concentrated under reduced 
pressure. Flash chromatography (florisil, 2% triethylamine, 30:1 = hex:EtOAc) yielded 
the desired product as a colorless oil. (0.49 g, 60%)  
 
TLC (hex:EtOAc 10:1)  
Rf = 0.33, stained by p-anisaldehyde  
 
1H NMR (500 MHz, CDCl3) δ 4.40 (d, J = 2 Hz, 1H), 4.22 (d, J = 2 Hz, 1H), 3.96 
(m, 1H), 3.68 (dd, J = 10, 5 Hz, 1H), 3.53 (dd, J = 10, 5 Hz, 1H), 2.22 (m, 1H), 2.14 (m, 
1H), 1.47 (s, 3H), 1.43 (s, 1H), 0.90 (s, 9H), 0.07 (d, J = 3.5 Hz, 6H).  
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Coupling product 2.69. Olefin 2.37 (36.9 mg, 0.14 mmol) was treated with a 
9-BBN 0.5 M solution in THF (0.4 mL, 0.20 mmol, 1.5 equiv.) under argon and the 
resultant solution was stirred at r.t. for 3 h. The reaction mixture was treated with 1 M 
aqueous NaHCO3 (0.4 mL, 3.0 equiv.). After stirring for 15 min, Pd(PPh3)4 (16 mg, 0.1 
equiv.) followed by a solution of cyclic ketene acetal phosphate 2.65 (67.5 mg, 1.5 equiv.) 
in DMF (0.17 mL) were successively added, and the resulting mixture was stirred at 
50 °C for 20h. After cooling, the reaction mixture was diluted with ether (diethyl 
ether:DMF = 10:1, 20 mL), washed with brine (10 mL), dried over Na2SO4, filtered and 
evaporated. The residue was dissolved in THF (5 mL) and cooled to 0 ˚C. The reaction 
was treated with 3 M NaOH (0.5 mL) followed by 30% H2O2 (0.2 mL). The resulting 
mixture was stirred at 23 °C for 30 min, diluted with ethyl acetate (20 mL), washed with 
saturated aqueous Na2SO3 and brine, dried over Na2SO4, filtered, and evaporated. Flash 
chromatography (SiO2, 8% ethyl acetate-hexane, 2% triethylamine) yielded the desired 
product. (44.7 mg, 92%)  
 
TLC (hex:EtOAc 10:1)  
Rf = 0.37, stained by p-anisaldehyde  
 
1H NMR (400 MHz, CDCl3) δ 4.54 (t, J = 3.6 Hz, 1H), 4.04 (m, 1H), 3.95 (m, 3H), 
3.67 (m, 1H), 3.47 (m, 1H), 2.35 (dd, 1H), 1.98 (m, 3H), 1.77 (m, 2H), 1.67 (dt, 1H), 1.44 
(s, 3H), 1.25 (s, 3H), 0.89 (s, 9H) 0.06 (d, J = 2.4 Hz, 6H).  
 
13C NMR(100 MHz, CDCl3) δ150.8, 98.8, 98.2, 70.1, 67.2, 67.1, 66.4, 41.9, 33.7, 
30.3, 29.9, 26.1, 22.6, 20.5, 20.1.  
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HRMS (ESI+)  
Calculated for C19H36O4Si Na: 379.2281  
Found: 379.2288  
 
 
Oxazolidinone 2.70. To a stirred solution of 4-pentenoic acid (570 mg, 5.70 
mmol, 1.0 equiv.) and triethylamine (0.63 mL, 5.98 mmol, 1.1 equiv.) in diethyl ether 31 
mL (vol. 2% of TEA) at -78 °C under nitrogen was added trimethylacetal chloride (520 
mg, 5.70 mmol, 1.0 equiv.). After 5 min, the bath was replaced by an ice-water bath and 
white precipitate was formed. The heterogeneous mixture was stirred at 0 °C for 1 h. In 
a separate flask, a solution of 4(R)benzyloxazolidin-2-one (1000 mg, 5.64 mmol, 1 
equiv.) in THF 6.8 mL (0.83 M of oxazolidinone) was cooled to -78 °C and nBuLi (1.6 M 
in hexane, 3.6 mL, 1.01 equiv.) was added slowly. After the second reaction mixture was 
stirred for 10 min at -78 °C, it was cannulaed over to the cooled down flask containing 
the anhydride at -78 °C. After stirring at this temperature for 15 min, the reaction 
mixture was warmed to 0 °C and stirred for an additional 30 min. After the reaction was 
quenched with water, the layers were separated and the aqueous layer was extracted 3 
times with diethyl ether. The combined organic layers were washed with brine, dried 
over Na2SO4, filtered and concentrated in vacuo. The residue was purified with flash 
chromatography (SiO2, hex:EtOAc = 3:1) and give product 2.70 a yield as a colorless oil 
which freezes as colorless crystals at -20 °C. (600 mg, 82%)  
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TLC (hex:EtOAc 3:1)  
Rf = 0.30, stained by KMnO4 
 
1H NMR (500 MHz, CDCl3) δ 7.34-7.20 (m, 5H), 5.87 (m, 1H), 5.11 (m, 1H), 5.04 
(m, 1H), 4.67 (m, 1H), 4.18 (m, 2H), 3.30 (dd, J = 13.5, 3 Hz, 1H), 3.04 (m, 2H), 2.76 (dd, 
J = 13.5, 10 Hz, 1H), 2.47 (m, 2H), 1.25 (s, 3H), 0.89 (s, 9H) 0.06 (d, J = 2.4 Hz, 6H).  
 
  
Alcohol 2.46. To a solution of NaHMDS (11 mL, 1 M in THF, 1.2 equiv.) and 
THF (18 mL) at -78 °C was added dropwise a solution of 2.70 (2.2 g, 1 equiv.) in THF 
(22.5 mL) at a rate that the internal temperature was kept below -70 °C. The resulting 
solution was stirred for 30 min at -78 °C before being cooled down to -95 °C. A 
precooled to -78 °C solution of Davis’ oxaziridine (3.34 g, 1.4 equiv.) in THF (15 mL) was 
added to the flask in a course of half an hour. After stirring for additional half an hour, 
the reaction was quenched with acetic acid (2.9 mL) in THF (60 mL). The reaction 
mixture was poured onto water and the organic layer was separated. The aqueous layer 
was extracted three times with EtOAc and the combined organic layers were 
successively washed with sat. aq. NaHCO3 and brine. The product was dried over 
Na2SO4 and concentrated in vacuo. After flash chromatography (SiO2, 
hex:EtOAc:toluene = 4:1:2) the product 2.46 was afforded in ~90% yield.  
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TLC (hex:EtOAc 3:1)  
Rf = 0.21, stained by KMnO4  
 
1H NMR (500 MHz, CDCl3) δ 7.30 (m, 5H), 5.87 (m, 1H), 5.13 (m, 2H), 4.67 (dm, 
J = 3 Hz, 1H), 4.27 (m, 2H), 3.55 (d, J = 8 Hz, 1H), 3.32 (dd, J = 13.5, 3.5 Hz, 3H), 2.84 
(dd, J = 13.5, 9.5 Hz, 2H), 2.62 (m, 1H), 2.46 (m, 1H), 1.25 (s, 3H), 0.89 (s, 9H) 0.06 (d, 
J = 2.4 Hz, 6H).  
 
 
 
 
 
Amide 2.71 A suspension of (MeO)NHMe HCl (289 mg, 5.25 equiv.) in THF (3.5 
mL) at 0 °C was treated with a solution of AlMe3 (2 M in toluene, 1.44 mL, 5.1 equiv.) 
dropwise and the resulting clear solution was stirred at 23 °C for 30 min. This clear 
solution was added to a cooled to 0 °C solution of 2.46 (155 mg, 1 equiv.) in THF (7 mL). 
The resulting mixture was warmed to 23 °C and stirred for 12 h. The reaction mixture 
was cooled to 0 °C, quenched by very slowly addition of 1 N. aq. tartaric acid and stirred 
at r.t. for 25 min. The layers were separated and the aqueous layer was extracted three 
times with EtOAc. The combined organic layer was dried over MgSO4 and concentrated 
in vacuo. Flash chromatography (SiO2, DCM:THF = 15:1) afforded the product 2.71. (85 
mg, with benzyloxazolidin-2-one impurity present)  
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TLC (hex:EtOAc 1:1)  
Rf = 0.30, stained by KMnO4  
 
1H NMR (500 MHz, CDCl3) δ 5.85 (m, 1H), 5.10 (m, 2H), 4.45 (b, 1H), 3.70 (s, 
3H), 3.33 (d, 1H), 3.22 (s, 1H), 2.49 (m, 1H), 2.33 (m, 1H).  
 
HRMS (ESI+)  
Calculated for C7H14O3N: 160.0974   
Found: 160.0974  
 
 
Vinyl magnesium bromide. 25 mL of 1 M vinyl bromide solution in THF was 
vigorously stirred with 7.0 g magnesium turning under nitrogen at 23 °C in a round 
bottom flask attached to a reflux condenser. The reaction mixture started refluxing in 
about 5 min. Continued to stir for one additional hour and a dark brown heterogeneous 
solution was formed. The solution is titrated by NoD 1H NMR technique described by 
Hoye†, giving a concentration of 0.74 M vinyl magnesium bromide.  
                                                   
 
 
† Hoye, T. R.; Eklov, B. M.; Voloshin, M. Org. Lett. 2004, 6, 2567-2570.  
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Bisolefin 2.48. To a stirred solution of 2.47 (260 mg, 0.95 mmol) in THF (10 
mL) at 0 °C was added vinyl magnesium bromide (2.6 mL, 1.9 mmol, 2 equiv.). After 
stirring at 0 °C for 15 min, to the reaction was added acetic anhydride (1.00 mL) 
followed by methanol (1.00 mL). The solution was reduced to one quarter the volume 
under reduced pressure then diluted to 50 mL with diethyl ether. The solution was 
washed with dilute aqueous ammonium chloride solution (5 mL sat. aq. NH4Cl and 
2.5mL water x 2) and dried over NaSO4. The solution was filtered and concentrated 
under reduced pressure at ambient temperature. Flash chromatography (SiO2, 
hex:EtOAc = 7:1) yielded 2.48 as a colorless oil (187 mg, 82%)  
 
TLC (hex:EtOAc 3:1)  
Rf = 0.72, stained by p-anisaldehyde  
 
1H NMR (500 MHz, CDCl3) δ 6.84 (dd, J = 17.5, 11 Hz, 1H), 6.38 (dd, J = 17.5, 2 
Hz, 1H), 5.77 (m, 2H), 5.08 (m, 2H), 4.21 (m, 1H), 2.40 (m, 2H), 0.94 (t, J = 8 Hz, 9H), 
0.60 (q, J = 8 Hz, 6H).  
 
HRMS (ESI+)  
Calculated for C15H32O3N: 302.2151  
Found: 302.2145  
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Ester 2.72. To a flask equipped with a stir bar and 24.67 g D-(R)-malic acid 
under nitrogen was added trifluoroacetic anhydride 62 mL at 0 °C. The ice bath was 
removed and the reaction was allowed to stir at r.t. for 2 h. The volatiles were 
evaporated under rotovap. Anhydrous ethanol alcohol (123 mL) was added to the white 
solid residue and the resulting solution was allowed to stir and 23 °C overnight. 
Concentration of the solution gave the pure malic monoester 2.72 in quantitative yield 
(29.7 g) that can be used in the next step without further purification. Recrystalization 
with hexanes/ethyl acetate gave the product as white crystals.  
 
1H NMR (500 MHz, CDCl3) δ 4.50 (dd, J = 6, 4 Hz, 1H), 4.28 (m, 2H), 2.89 (m, 
3H), 1.31 (t, J = 7.5 Hz 2H).  
 
13C NMR(125 MHz, CDCl3) δ174.4, 173.2, 67.1, 62.5, 38.3, 14.2.  
 
HRMS (ESI+)  
Calculated for C6H10O5Na: 185.0426  
Found: 185.0430   
 
Dioxanone 2.57. To a stirred solution of monoester 2.72 (8.9 g, 54.96 mmol) 
in 1370 mL anhydrous CH2Cl2 (0.04 M) under nitrogen, was added 1-
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methoxycyclopentene (16.2 g, 18.0 mL, 164.88 mmol) and PPTS (414.4 mg, 1.65 mmol) 
at 23 °C, and the reaction was allowed to stir at this temperature for 16h, before an 
aqueous solution of (1:1 H2O : sat. aq. NaHCO3) total of 733 mL was added to quench 
the reaction. The layers were separated and the aqueous layer was extracted three times 
with 366 mL of CH2Cl2. The combined organic layer was dried over 133 g Na2SO4 and 
filtered. Concentration of the solution gave the dioxanone 2.57 (11.6 g, 93%) that is used 
in the next reaction without further purification.  
 
TLC (hex:EtOAc 1:1)  
Rf = 0.24, stained by p-anisaldehyde  
 
1H NMR (500 MHz, CDCl3) δ 4.60 (dd, J = 10, 5 Hz, 1H),  4.27 (q, J = 7 Hz, 2H), 
2.85 (m, 2H), 2.03 (m, 4H), 1.81(m, 4H), 1.32 (t, J = 7 Hz, 3H).  
 
HRMS (ESI+)  
Calculated for C11H16O5Na: 251.0895   
Found: 251.0904 
 
 
Dimethyl titanocene. To a solution of titanocene dichloride (13.34 g, 53.6 
mmol) in 146 mL toluene in a 500 mL flask was dropwise added MeMgCl (3 M in THF, 
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150 mmol) at 0 °C. The reaction was allowed to stir in dark at 0 °C for 1 h, and 37 mL 6% 
NH4Cl aqueous solution was added. The layers were separated and the organic layer was 
washed with 37 mL water three times and once 37 mL brine. The organic solution was 
dried with 37 g Na2SO4 and concentrated to a smaller volume. The resulting orange 
solution was titrated with 1H NMR. The ideal concentration should be around 0.63 
mol/g solution, and this solution can be stored in dark under argon at -20 °C for up to 
two weeks.  
 
Methylene dioxane 2.73. Dioxanone 2.57 (1.0 g, 4.39 mmol), titanocene 
dichloride (65.5 mg, 0.26 mmol) and dimethyltitanocene toluene solution (0.63 mmol/g 
solution, 11.8 g) was stirred in a 40 mL sealed vial filled with argon. The solution was 
allowed to react in dark at strict 70 °C for 4 h. After the reaction was cooled to 23 °C, 1 
mL sat. aq. NaHCO3 and 2 mL EtOH was added and the mixture was allowed to stir at 
40 °C for 12 h open to air. The mixture was passed through a plug of florisil and flushed 
with CH2Cl2 before concentration in vacuo. Flash chromatography gave 2.73 (644 mg, 
65%) as a light yellow oil.  
 
TLC (hex:EtOAc 5:1)  
Rf = 0.35, stained by p-anisaldehyde  
 
1H NMR (500 MHz, CDCl3) δ 4.48 (s, 1H),  4.39 (dd, J = 11, 5 Hz, 1H), 4.31 (s, 1H), 
4.24 (q, J = 7 Hz, 2H), 2.51 (m, 2H), 2.04 (m, 3H), 1.71 (m, 5H), 1.30 (t, J = 7 Hz,  3H).  
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HRMS (EI+)  
Calculated for C11H16O4: 226.1205  
Found: 226.1206  
 
 
Phosphonate 36. To a stired solution of dimethyl methylphosphonate (1.74 g, 
14.1 mmol) in 5.5 mL THF cooled to -78 °C under nitrogen was added n-BuLi (1.6 M, 8.8 
mL, 14.1 mmol) dropwise. After stirring the same temperature for 1h, ethyl ester 45 
(1.06 g, 4.69 mmol) was added and the resulting solution was stirred at -78 °C for 1 h. 
The reaction was warmed to 0 °C and stirred for another 1 h before quenched with 2.5 
mL sat. aq. NaHCO3. The mixture was passed through a pad of celite and flushed with 
EtOAc. Flash chromatography gave the product (1.01 g, 71%) as a colorless oil.  
 
TLC (hex:EtOAc 1:2)  
Rf = 0.26, stained by p-anisaldehyde  
 
1H NMR (500 MHz, CDCl3)  
δ 4.49 (d, J = 2 Hz, 1H),  4.34 (m, 1H), 4.33 (d, J = 2 Hz, 2H), 3.80 (dd, J = 11, 5 
Hz, 6H), 3.55 (m, 1H), 3.16 (m, 1H), 2.46 (m, 1H), 2.35 (m, 1H), 2.10 (m, 1H), 2.01 (m, 
1H), 1.73 (m, 6H).  
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HRMS (ES+)  
Calculated for C11H19O6PNa: 301.0817  
Found: 301.0813  
 
 
Enone 2.73. To a solution of 2.58 (405.7 mg, 1.33 mmol) in 13.3 mL CH3CN 
under nitrogen was added LiCl (112.8 mg, 2.66 mmol, 120C over dried overnight). After 
stirred at 23 °C for 10 min, DIPEA (343.8 mg, 2.66 mmol) was added dropwise and the 
mixture was allowed to stir for another 25 min. The mixture was then cooled to 0 °C and 
2.55 (322.7 mg, 1.33 mmol) in 2.5 mL CH3CN was added. The reaction was stirred at 
23 °C for 4 h before it was quenched with 5 mL brine. The layers were separated and the 
aqueous layer was extracted three times with CH2Cl2. The combined organic layer was 
dried over Na2SO4 and concentrated in vacuo. Flash chromatography furnished 2.73 
(376.2 mg, 67%).  
 
TLC (hex:EtOAc 2:1)  
Rf = 0.51, stained by p-anisaldehyde  
 
1H NMR (500 MHz, CDCl3) δ 6.93 (dd, J = 15.5, 4 Hz, 1H),  6.72 (dd, J = 16, 1.5 
Hz, 2H), 4.51 (m, 1H), 4.48 (d, J = 1.5 Hz, 1H), 4.38 (dd, J = 12, 4 Hz, 1H), 4.32 (d, J = 
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1.5 Hz, 1H), 4.29 (m, 1H), 3.70 (s, 3H), 2.59 (m, 1H), 2.42 (m, 1H), 2.39 (m, 2H), 2.13 (m, 
1H), 1.97 (m, 7H), 1.71 (m, 11H).  
 
HRMS (ES+)  
Calculated for C23H33O7: 421.2226  
Found: 421.2230  
 
O
O OOMeO
O
O
O
O OOMeO
O
O
Stryker's reagent
74%
2.73 2.62  
Ketone 2.62. Stryker’s reagent ([(Ph3P)CuH]6, 1.76 g, 0.90 mmol) was added to 
a solution of enone 2.73 (344.2 mg, 0.82 mmol) in 40 mL toluene in the glove box. The 
mixture was allowed to stir at 23 °C for 1 h. 13 mL hexanes was added to the reaction 
flask and the reaction was exposed to air. It was allowed to stir for another 1 h at 23 °C 
before concentration under reduced pressure. Flash chromatography afforded 2.62 
(253.2 mg, 74%).  
 
TLC (hex:EtOAc 2:1)  
Rf = 0.57, stained by p-anisaldehyde  
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1H NMR (500 MHz, CDCl3) 4.47 (s, 1H), 4.31 (s, 1H), 4.21 (m, 3H), 3.75 (m, 1H), 
3.68 (s, 3H), 2.69 (m, 2H), 2.57 (m, 1H), 2.41 (m, 2H), 2.29 (m, 1H), 2.09 (m, 1H), 2.01 
(m, 1H), 1.93 (m, 1H), 1.68 (m, 15H).  
 
HRMS (ES+)  
Calculated for C23H34O7Si Na: 445.2202  
Found: 445.2203 
 
 
Alcohol 2.74. L-selectride (1 M in THF, 264 uL, 0.264 mmol) was added to a 
solution of ketone 2.62 (106.2 mg, 0.252 mmol) in 5.5 mL THF under nitrogen at -
110 °C. The bath temperature was raised to -78 °C in the course of 15 min, before finally 
warmed to 0 °C. 0.44 mL 6 M NaOH and 0.37 mL 30% H2O2 was added to the reaction. 
After 30 min, 7.4 mL of Et2O was added the layers were separated. The organic layer 
was washed with 0.74 mL 10% sat. aq. Na2S2O3, two times 0.74 mL sat. aq. NaHCO3, 
and 0.74 mL brine. The combined organic layer was dried over Na2SO4 and 
concentrated in vacuo to give the alcohol 2.74 (106 mg, 100%). The crude material was 
directly used in the next reaction without further purification.  
 
TLC (hex:EtOAc 2:1)  
Rf = 0.34, stained by p-anisaldehyde  
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1H NMR (500 MHz, CDCl3) 4.43 (d, J = 2 Hz, 1H), 4.25 (d, J = 1.5 Hz, 1H), 4.21 
(m, 2H), 3.77 (m, 1H), 3.69 (s, 3H), 3.47 (m, 1H), 2.56 (m, 2H), 2.40 (m, 1H), 2.27 (m, 
1H), 2.10 (m, 2H), 1.80 (m, 20H).  
HRMS (ESI+)  
Calculated for C23H36O7Na: 447.2341  
Found: 447.2359  
 
 
Silyl ether 2.63. To a stirred solution of 2.74 (85.1 mg, 0.2 mmol) and 2,6-
lutidine (322.6 mg, 30.0 mmol) in 4 mL hexanes under nitrogen at -78 °C was added 
TBSOTf (159 mg, 0.6 mmol) slowly. After 3 h, additional TBSOTf (26.6 mg, 0.1 mmol) 
was added and after 0.5 h, the reaction was quenched with 2 mL of sat. aq. NaHCO3. 
The reaction was allowed to warmed to 23 °C while maintaining stirring. Layers were 
separated and the aqueous layer was extracted with three times of Et2O. The combined 
organic layer was dried over Na2SO4 and concentrated in vacuo. Flash chromatography 
afforded silyl ether 2.63 (75 mg, 71%).  
 
TLC (hex:EtOAc 5:1)  
Rf = 0.24, stained by p-anisaldehyde  
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1H NMR (500 MHz, CDCl3) 4.47 (s, 1H), 4.31 (s, 1H), 4.21 (m, 3H), 3.75 (m, 1H), 
3.68 (s, 3H), 2.69 (m, 2H), 2.57 (m, 1H), 2.41 (m, 2H), 2.29 (m, 1H), 2.09 (m, 1H), 2.01 
(m, 1H), 1.93 (m, 1H), 1.68 (m, 15H). 
HRMS (ESI+)  
Calculated for C29H51O7SiNa: 539.3404  
Found: 539.3389  
 
 
“northern” AmB 2.66. 2.63 (20 mg, 0.037 mmol) was stirred with 9-BBN 
(0.5 M in THF, 89 uL, 0.045 mmol) and 0.27 mL additional THF in the glove box at 
23 °C for 1.5 h. A premixed solution of SPhos (4%, 0.61mg) and Pd(OAc)2 (2%, 0.17 mg) 
in 50 uL THF was added to the first flask. K3PO4 (23.7 mg, 0.112 mmol) and a solution 
of 2.65 (18.5 mg, 0.056 mmol) in 0.9 mL DMF was also added to the first flask. The 
heterogeneous mixture was allowed to stir at 50 °C for 24 h. The reaction mixture was 
allowed to pass through a pad of florisil and the solvent was removed under reduced 
pressure. The yield of the product was not determined at this point.  
 
HRMS (ESI+)  
Calculated for C34H59O8Si:623.3979  
Found: 623.4005  
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Chapter 3 
 
Second generation synthesis of BB1  
 
As discussed in chapter 2, in the first generation synthesis, late stage 
intermediate 2.63, as well as several of its exo-methylene dioxane moiety containing 
precursors readily undergo an undesired isomerization. In addition, BB1 2.64 is an air 
sensitive 9-BBN alkyl borane which has to be prepared in situ from 2.63 prior to the 
coupling. None of these intermediates are good candidates for a storage “check point” 
that is crucial for constructing an efficient and modular ICC-based synthesis.1  
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In sharp contrast to most organoboron compounds such as 2.63, MIDA 
boronates-containing substrates have demonstrated extraordinary bench-top stability 
and reagent compatibility.2, 3 Meanwhile, MIDA boronates, which are often crystalline 
solids, can be readily hydrolyzed with mild aqueous base to the corresponding boronic 
acids for subsequent cross-couplings. Thus, in our second generation synthesis, we 
planned to convert the sensitive exo-methylene dioxane moiety early in the route to the 
primary Csp3 MIDA boronate and carry it through multiple steps to access building 
block BB1.  
 
Scheme 3.1. Proposed hydrolysis of BB1-MIDA to BB1-boronic acid.  
 
To enable this proposal, three challenges has to be solved: 1. establishing a new 
synthesis of MIDA boronates (a route to the targeted Csp3 MIDA boronate was 
unknown); 2. carrying MIDA boronate through a multiple-step synthetic route to BB1; 
3. hydrolyzing Csp3 primary BB1-MIDA boronate to BB1-boronic acid and cross-
couple it to BB2 under a Csp3-Csp2 Suzuki-Miyaura condition. Successful development 
of this approach stood not only to provide an efficient route to a building block, but also 
to provide a venue to build the ubiquitous Csp3-Csp2 bond and enable the development 
of methods to target molecules beyond the scope of this synthesis.   
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3.1  Cross-coupling of primary Csp3 boronic acids  
With the advancement of new catalysts, cross-couplings of Csp2 hybridized aryl, 
vinyl, and heteroaryl boronic acids with a variety of substitution patterns can now be 
routinely performed. In contrast, the scope of Csp3 boronic acid cross-couplings is 
practically very limited due to the inherently slower transmetalation and reductive 
elimination. In addition, notoriously poor stability of Csp3 boronic acids has made 
handling and storage of these compounds difficult. Early examples of cross-coupling 
Csp3 boronic acids and boronic esters are limited to unbranched primary substrates.4-7  
.  
Scheme 3.2. Cross-coupling of β-substituted Csp3 primary boronic acids.   
 
Scheme 3.3. Proposed of 2nd generation BB1-BB2 cross-coupling.   
 
In 2005, Taylor reported that by applying silver oxide as an additive, cross 
coupling of primary boronic acids with increased structural complexity can also be 
achieved (Scheme 3.2).4 Under his optimized condition, β -nitrogen containing 
primary Csp3 boronic acids were successfully coupled to a series of aryl halides with 
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modest yields. The Taylor system somewhat resembles the BB1-BB2 cross-coupling of 
β-oxygen containing primary Csp3 boronic acid BB1 3.2 in our route. Intrigued by this 
result, a screen of model cross-coupling with commercially available primary and 
secondary Csp3 boronic acids was performed (Scheme 3.3).  
 
Scheme 3.4. Cross-coupling of Csp3 boronic acids with bromoacetophenone.   
 
 
Scheme 3.5. Cross-coupling of octylboronic acids with halides and pseudo-halide.   
 
Applying the silver oxide promoted condition, both primary octylboronic acid 3.3 
and iso-butylboronic acid 3.4 coupled well with 4-bromoacetophenone. More 
interestingly, cross-coupling of unactivated secondary Csp3 cyclopentylboronic acid 3.5 
Chapter 3 Second generation synthesis of BB1  64 
also gave surprisingly good yield. Following up on this interesting observation led to the 
development of a novel method for site- and stereo-retentive cross-coupling of 
unactivated chiral secondary boronic acids, which is described in chapter 5.  
We next examined different halides and pseudo-halides for this reaction 
(Scheme 3.5). Aryl iodide is a competent coupling partner for this reaction, while aryl 
chloride failed to yield the desired product. In a more important study, BB2 analog 
cyclic ketene phosphate 3.8 gave no detectable product under this condition. This 
problem was solved through a quick screen, and it was found that Buchwald’s 
anhydrous condition can promote the Csp3-Csp2 cross-coupling efficiently (Scheme 
3.6).  
 
Scheme 3.6. Cross-coupling of  Csp3 boronic acids with BB2 analog 3.8.   
 
3.2  Synthesis of alkyl MIDA boronates  
Having established a reliable primary Csp3 boronic acid cross-coupling with 
ketene acetal phosphate, we next targeted to find a synthesis of Csp3 MIDA boronates. 
Examples of existing synthesis of MIDA boronates are demonstrated in Scheme 3.7 
and can be summarized into three categories: 1. condensation of boronic acid with 
MIDA under Dean-Stark condition;2 2. hydroboration with tribromoborane followed by 
trapping with MIDA ligand (Eqa. 3.1);2, 8 3. attack of trialkyl borate with preformed 
organometallic nucleophile followed by trapping with MIDA ligand (Eqa. 3.2 and 
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3.3).9, 10 The Dean-Stark procedure requires a pre-formed C-B bond. In the latter two 
cases, harsh reaction conditions are needed, which presumably led to only fair to 
moderate yields. In addition, high boiling DMSO is the solvent of choice in the second 
step which makes purification of the product challenging.  
 
Scheme 3.7. Existing methods for the synthesis of MIDA boronates.   
 
 
Scheme 3.8. Potential elimination of alkyl organometallic substrate in the presence of 
β-oxygen.   
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In our synthesis of Csp3 primary MIDA boronate, we first ruled out the formation 
of organometallic nucleophiles such as 3.10. β-elimination is likely to occur in the 
presence of β-oxygen containing carbon center to yield terminal olefin 3.11, following 
the mechanism proposed in Scheme 3.8.  
We then attempted hydroboration condition of intermediate 3.12 from the first 
generation synthesis with dibromoborane dimethylsulfide complex. In practice, 
decomposition of the substrate was observed which was presumably caused by the 
presence of strong electrophile dibromoborane.  Upon complexation with MIDA, only 
less than 5% yield of 3.13 was isolated (Scheme 3.9).  
 
Scheme 3.9. Low yielding synthesis of Csp3 MIDA boronate building block with 
HBBr2.Me2S.   
 
In 2003, Snieckus and coworkers reported a synthesis of alkyl boronic acids by 
hydroboration of the olefin with the “Snieckus borane” 3.14.The two alkyl ligands on 
the hydroborated intermediate 3.15 are cleaved first by water, followed by 
formaldehyde to give boronate 3.17 (Scheme 3.10). Corresponding boronic acid can 
be prepared from hydrolysis of 3.17.  
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Scheme 3.10. Snieckus synthesis of boronate 3.17.   
 
Building on this procedure, we were able to synthesize boronate 3.17 from 3.12. 
Upon complexation with MIDA, the desired MIDA boronate 3.13 was isolated in 51% 
yield. Furthermore, in an unoptimized experiment, we discovered that a direct 
transligation from the Snieckus hydroborated intermediate 3.15 to the MIDA boronate 
was also possible. We hypothesized that a similar 6-centered rearrangement is operative 
in this process (Scheme 3.11). Only the syn- diastereomer was observed.  
 
Scheme 3.11. Proposed mechanism for a direct transligation from Snieckus borane to 
MIDA boronate.   
 
Chapter 3 Second generation synthesis of BB1  68 
3.3  Second generation synthesis of BB1 in the form 
of MIDA boronate and cross-coupling of BB1-
B(OH)2 with BB2  
3.3.1 Synthesis of BB1-MIDA and first attempt of BB1-
B(OH)2 cross-coupling  
With MIDA boronate 3.13 in hand, we proceeded with the BB1 synthesis via a 
modified route (Scheme 3.12). Reaction with alkyl lithium to form phosphonate 3.18 
was accompanied with partial decomposition of the MIDA boronate and gave a 
moderate 47% yield. This is, however, the only time in the new route that we observed a 
loss of the product due to the stability of MIDA boronate moiety. Horner-Wadsworth-
Emmons reaction with aldehyde 3.19 went smoothly to afford cross-coupled 
intermediate 3.20 in 60% yield. Finally, diastereoselective reduction with (R)-CBS, 
hydrogenation of the resulting olefin, and TBS silylation of C8 alcohol gave BB1-MIDA 
3.1. It is noteworthy to point out that it was the first time MIDA boronate was shown to 
be compatible (or at least partially compatible) with reagents and reaction conditions 
that are labeled in blue.  
Hydrolysis of 3.1 took place readily under standard aqueous NaOH condition, 
furnishing BB1-B(OH)2 3.2 in quantitative yield. With this building block in hand, we 
went on to examine the cross-coupling reaction with the valerolacton-derived BB2 
analog 3.8. To our surprise, under the same condition that gave 71% cross-coupled yield 
(Scheme 3.6) for octylboronic acid 3.3 and valeralactone derived cyclic ketene acetal 
phosphate 3.8, no product was observed (Scheme 3.13).  
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Scheme 3.12. Synthesis of BB1-MIDA (3.1).   
 
 
Scheme 3.13. Failed cross-coupling of BB1-B(OH)2  (3.1) and BB2 analog (3.8).   
 
With questionable comparison, Csp2 iodide may be more reactive than Csp2 
phosphates to couple with Csp3 boronic acids. In addition, triflate is considered to be an 
equally or more reactive functional group compared to phosphate.11 Thus, as part of our 
search for a practical coupling, we also included triflate 3.21 and vinyl iodide 3.22 
derived from glucal as well as phosphate 3.8.  
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Figure 3.1.  
 
Over 200 conditions were screened in an attempt to find a practical coupling 
between BB1 and BB2 (Table 3.1). However, no reaction showed any conversion to 
the desired product, analyzed by TLC, mass spectrometry and crude 1H NMR analysis. 
The only difference between this system and model reaction (Scheme 3.6) is β-
substitution of the primary boronic acid. Based on this analysis, we proposed that 
preparation of a more active boron nucleophile might solve the problem. 
 
BB1  BB2  Metal  Ligand  Base  Solvent  Additive 
3.2 3.8 Pd(OAc)2  Sphos  K2CO3  THF  Ag2O  
  3.21 Pd(dppf)Cl2  Xphos  K3PO4  DMF  AgO  
  3.22 Pd(PPh3)4  Cy2Johnphos CsCO3  toluene  Ag2CO3 
    Pd2dba3  t-Bu2MeP  NaHCO3 dioxane  AgBF4  
    Pd(MeCN)2Cl2 Cy3P  KHCO3    CuTC  
    Ni(COD)2  Ad2t-BuP  NaOH    CuBr  
    NiI2  Ph3As  Tl2CO3    CuCl  
       Qphos      KF  
 
Table 3.1. An partial list of BB1-BB2 cross-coupling conditions screened. Selected 
combinations from different columns have been examined. Not all combinations have 
been screened.  
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3.3.2 Csp3-Csp2 cross-coupling of boron ate- complex  
In contrast to other palladium mediated organometallic cross-coupling reactions, 
addition of base is necessary to promote Suzuki-Miyaura couplings.12, 13 One proposed 
role of the base is an activator to form the nucleophilic boron ate- complex from 
electrophilic boronic acid. Therefore, a faster boron ate- complex formation might 
increase the rate of the cross-coupling. This hypothesis could be employed to explain the 
fact that alkyl boranes (such as first generation BB1-9-BBN 2.64) that is easier to form 
the ate- complex is much more reactive than their boronic acid counterparts (BB1-
B(OH)2 3.1) under cross-coupling conditions.14 To take advantage of this phenomenon, 
Miyaura was able to cross-couple the preformed boronate ate- complex without the 
addition of any base (Scheme 3.14).15 In addition, except for a handful of cases where 
Johnphos ligand was used, the Miyaura triolborate is very active that high-yielding 
cross-coupling can be achieved even without addition of a ligand at room temperature. 
Inspired by this report, we prepared a series of boron ate- complexes with different 
electronic and steric characteristics using Miyaura’s complexation condition and tested 
them in a simple aryl-aryl cross-coupling, in hope to find a candidate that is more active 
than the boronic acid to promote the BB1-BB2 coupling. For the purpose of this screen, 
we used a Pd(OAc)2 and Johnphos combination, one of the standard conditions from 
Miyaura’s report.  
 
Scheme 3.14. Cross-coupling of the Miyaura triolborate.   
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Depicted in Scheme 3.15, both boronic acid with K3PO4 and Miyaura’s 
triolborate afforded full conversion under the catalyst condition. Borate 3.25 which has 
a more rigid cyclohexyltriol ligand gave decreased conversion while 3.26, a more 
electronic deficient version of the Miyaura’s borate 3.24, was inactive.  
 
 
Scheme 3.15. Comparison of different boron nucleophiles under Csp2-Csp2 cross-
coupling conditions.   
 
We next prepared these borates (3.27, 3.28, 3.29) from butylboronic acid and 
evaluated their reactivity under Csp3-Csp2 cross-coupling conditions (Scheme 3.16). 
With the Pd(OAc)2 plus Johnphos catalyst/ligand combination, no conversion for any of 
the tested boron nucleophile was observed even at elevated temperature as high as 85˚C. 
Next, the same series of borates were subjected to the Taylor condition.4 As it turned out, 
low conversion was observed for borates 3.28 and 3.29 while coupling of the Miyaura 
borate 3.27 yielded a significant amount of byproduct that was identified to be the 
proto-dehalogenated acetophenone. Meanwhile, butylboronic acid plus Ag2O afforded 
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full conversion. From these studies, it is safe to conclude that boronic acid plus base is 
more reactive than the other three preformed borate ate- complex. 
 
Scheme 3.16. Comparison of different boron nucleophiles under Csp3-Csp2 cross-
coupling conditions.   
 
Another example of preformation alkyl boronate ate- complex strategy was 
reported by Falck in 2001.16 Instead of an anionic borate, butyl pinacol borate was 
treated with sec-BuLi to form the active ate- complex 3.30, which was subsequently 
coupled with an aryl halide under a cross-coupling condition without external base 
(Scheme 3.17).  
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 Scheme 3.17. Cross-coupling of lithium alkylborates.   
 
Following this precedent, we thereby prepared Csp3 pinacol borate 3.32 by 
transligation from MIDA boronate 3.32 in a model system. Once again, attempt for this 
tricky Csp3-Csp2 cross-coupling reaction was not met with success (Scheme 3.18).  
 
Scheme 3.18. Cross-coupling of lithium alkylborates.   
 
 
Figure 3.2. Diol ligands with different steric profiles.  
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Scheme 3.19. Cross-coupling of ethylene glycol borate.   
 
Building on this platform, we next synthesized a variety of borates by treating 
MIDA boronate 3.31 with diols listed in Figure 3.2, trying to create a variety of steric 
environment around coupling site. In all cases transligation proceeded well to afford 85-
99% of the borate. However, the sole positive result was from cross-coupling the least 
steric encumbered ethylene glycol borate 3.34 with triflate 3.21 that afforded only 7% 
of the desired product 3.33 (Scheme 3.19).  
 
3.3.3  Csp3-Csp2 cross-coupling of electron deficient borates  
Having been unsuccessful to couple electron-rich borate “ate-“ complex, we took 
a different approach by synthesizing borates that are electron poor. The logic behind our 
proposal is that such borate might in fact have a lower energy barrier to react with the 
base and better stabilize the “ate-“ complex. Guided by this principle, a series of catechol 
derived borates were synthesized. However, none of these showed promising results in 
the cross-coupling reaction. Currently, these results led us to pursue a third generation 
synthesis of BB1.  
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Figure 3.3. Diol ligands with different electronic profiles.  
 
3.4  Experimental section  
Materials.  Commercial reagents were purchased from Sigma-Aldrich, Fisher 
Scientific, Alfa Aesar, TCI America, or Frontier Scientific, and were used without further 
purification unless otherwise noted.  
Solvents were purified via passage through packed columns as described by 
Pangborn and coworkers1 (THF, Et2O, CH3CN, CH2Cl2: dry neutral alumina; hexane, 
benzene, and toluene, dry neutral alumina and Q5 reactant; DMSO, DMF: activated 
molecular sieves). All water was deionized prior to use. Diisopropylethylamine was 
freshly distilled under an atmosphere of nitrogen from CaH2.  
 
General experimental procedures.  Unless noted, all reactions were 
performed in flame-dried round bottom or modified Schlenk flasks fitted with rubber 
septa under a positive pressure of argon or nitrogen. Organic solutions were 
concentrated via rotary evaporation under reduced pressure with a bath temperature of 
23 oC unless otherwise noted. Reactions were monitored  by analytical thin layer 
chromatography (TLC) performed using the indicated solvent on E. Merck silica gel 60 
F254 plates (0.25mm).  Compounds were visualized by exposure to a UV lamp (λ = 254 
nm), and/or a solution of KMnO4 and/or a solution of p-anisaldehyde, followed by brief 
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heating using a Varitemp heat gun. Column chromatography was performed using 
Merck silica gel grade 9385 60Å (230-400 mesh).  
 
Structural analysis. 1H NMR and 13C NMR spectra were recorded at 20 oC on 
Varian Unity 500, Varian Unity Inova 500NB or Varian Unity 500 instruments.  
Chemical shifts (δ) are reported in parts per million (ppm) downfield from 
tetramethylsilane and referenced to residual protium in the NMR solvent (benzene, δ = 
7.16; CHCl3, δ = 7.26; acetone, δ = 2.05, center line; DMSO δ = 2.50, center line) or to 
added tetramethylsilane (δ = 0.00).  Data are reported as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sept = 
septet, m = multiplet, b = broad, app = apparent), coupling constant (J) in Hertz (Hz), 
and integration.  Chemical shifts (δ) for 13C NMR are reported in ppm downfield from 
tetramethylsilane and referenced to carbon resonances in the NMR solvent (benzene-d6, 
δ = 128.06, center line; CDCl3, δ = 77.0, center line; acetone-d6,  δ = 39.5, center line; 
DMSO-d6 δ = 39.52, center line). Carbons bearing boron substituents were not 
observed (quadrupolar relaxation). High resolution mass spectra (HRMS) were 
performed by Furong Sun, Elizabeth Eves and Dr. Haijun Yao at the University of 
Illinois School of Chemical Sciences Mass Spectrometry Laboratory.   
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Under argon atmosphere, a 25 mL round-bottom-flask equipped with a stir bar 
was charged with diene 3.35 (1.06 mL, 2.20 equiv.) in 1.06 mL THF was slowly added 1 
M solution of (3.47 mL, 1.05 equiv.) BH3.THF at 0 °C. The reaction was allowed to stir at 
this temperature for 3h and was used in the hydroboration as a solution.  
 
 
3.12 (754 mg, 3.34 mmol, 1.0 equiv.) was added to above solution in 1.97 mL 
THF. The reaction was then allowed to stir at 23 °C for 3 h before slowly added 0.45 mL 
water. After stirring at 23 °C for another 2 h, 0.26 mL 37% formaldehyde aqueous 
solution was added and the mixture was allowed to stir for 24 h.  
 
The borane mixture was diluted with 3.32 mL of EtOAc and 6.7 mL of DMSO. 
MIDA ligand (0.74 g, 1.5 equiv.) was then added as a solid and was connected to a short 
path distillation condenser. The reaction was placed in an oil bath under house vacuum. 
the temperature was brought up to 50 °C and the mixture was allowed to stir at for 1 h. 
In this way, water as well as most low-boiling organic molecules were removed. At the 
same temperature, DMSO was distilled under reduced pressure. The off-yellow crude 
mixture was purified through flash column to give 674 mg 3.13 (53%)  
 
Chapter 3 Second generation synthesis of BB1  79 
1H NMR (499 MHz, Acetone) δ 4.45 (dd, J = 12.5, 3.0, 1H),  4.25 (d, J = 17.0, 1H), 
4.17-4.13 (m, 3H), 4.00 (d, J = 17.5, 1H) 3.95-3.91 (m, 2H), 3.15 (s, 3H), 1.96-1.74 (m, 
5H), 1.66-1.45 (m, 5H), 1.24 (t, J = 7.5, 3H), 1.05-0.95 (m, 2H).  
 
HRMS (ESI+)  
Calculated for C17H26BNNaO8: 406.1649  
Found: 406.1637  
 
To a stirred solution of 3.36 (2.21 g, 6.0 equiv.) in 40 mL THF in a 100 mL RBF 
under argon was dropwise added 1.6 M nBuLi (11.4 mL, 6 equiv.) at -78°C. After 0.5 h, a 
solution of 1.14 g 3.13 in 4 mL THF was added via cannula. In 3.5 h, 11.44 mL (v:v=3:5) 
acetic acid in THF was slowly added while vigorously stirring. After stirring at -78°C for 
2 min, the cold bath was removed and 22.9 mL half sat. aqueous NH4Cl was added and 
the mixture was extracted with EtOAc 5 times. Drying with Na2SO4 was followed by 
concentration under reduced pressure. Flash column followed by recrystallization from 
acetone:Et2O:hexanes afforded 3.18 as a white crystalline spindle in 47% (643 mg).  
 
1H NMR (400 MHz, Acetone) δ 4.45-4.41, (dd, J = 12, 8, 1H), 4.25 (d, J = 17.2, 1H) 
4.15 (d, J = 16.0, 1H), 4.01 (d, J = 17.2, 1H), 3.95-3.91 (m, 2H), 3.74-3.70 (m, 6H), 3.52-
Chapter 3 Second generation synthesis of BB1  80 
3.42 (m, 1H), 3.22-3.13 (m, 1H), 3.15 (s, 3H), 2.13-1.83 (m, 4H), 1.76-1.59 (m, 5H), 1.42-
1.32 (m, 1H), 1.07-0.95 (m, 2H).  
 
HRMS (ESI+)  
Calculated for C18H29BNNaO10P: 484.1520  
Found: 484.1527  
 
 
 
To a stirred solution of 3.18 (757 mg, 1.0 equiv.) in 16.4 mL MeCN in a 100 mL 
RBF under argon at 23°C was added 209 mg oven dried LiCl (3.0 equiv.). In 15 min, 
0.86 mL DIPEA (3.0 equiv.) was added. In another 25 min, 3.19 in 8.2 mL MeCN was 
cannulaed over at 0°C. The reaction was let stir at 23°C for 2.5 h before being quenched 
with 12.8 mL sat. aqueous NH4Cl. The mixture was extracted with EtOAc 5 times. 
Drying over MgSO4 was followed by concentration under reduced pressure. Crude yield 
was 770 mg, (83%) and after column purification afforded the product as a white solid 
557 mg (60%).  
 
1H NMR (499 MHz, Acetone) δ 6.87 (dd,  J = 15.5, 4, 1H) 6.70 (dd, J = 15.5, 1.5, 
1H), 4.64-4.61 (m, 1H), 4.52 (dd, J = 12, 3.0, 1H),  4.33-4.31 (m, 1H), 4.25 (d, J = 17.0, 
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1H), 4.15 (d, J = 16.5, 1H), 4.01 (d, J = 17.5, 1H), 3.98-3.97 (m, 1H), 3.94 (d, J = 16.5, 1H), 
3.63 (s, 3H), 3.17 (s, 3H), 2.49-2.46 (m, 2H), 1.99-1.58 (m, 17H), 1.41-1.20 (m, 3H), 1.60-
0.50 (m, 2H).   
 
HRMS (ESI+)  
Calculated for C28H40BNNaO11: 600.2592  
Found: 600.2600  
 
 
In a 40 mL IChem vial equipped with a stir bar under argon, a 1 M solution (R)-
CBS (0.44 mL, 1.0 equiv.) was diluted with 1.5 mL THF. The solution was cooled to -
10 °C and was added 0.46 mL 2.0 M BH3.Me2S in toluene (2.1 equiv.). In 10 min, a 
solution of 3.20 in 4.3 mL THF was added and the mixture was allowed to stir at the 
same temperature for 1 h before 5 mL sat. aqueous NH4Cl was added to quench the 
reaction. After vigorously stirring for 1 h, layers were separated and the aqueous layer 
was extracted with EtOAc x 5. Drying over Na2SO4 before filtered through a pad of 
celite. Concentration under reduced pressure afforded the product 3.37 which was used 
directly into the next reaction without further purification. Crude yield, 250 mg, 98%  
 
1H NMR (499 MHz, Acetone) δ 5.78-5.69 (m, 2H), 4.40-4.36 (m, 1H), 4.29-4.21 
(m, 2H), 4.12 (d, J = 16, 1H),  4.00 (d, J = 17.5, 1H), 3.95-3.90 (m, 2H), 3.88-3.83 (m, 
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1H), 3.72-2.66 (m, 2H), 3.63 (s, 3H), 3.15 (s, 3H), 2.49-2.40 (m, 2H), 2.04-1.53 (m, 17H), 
1.32-1.22 (m, 3H), 1.02-0.89 (m, 2H).   
 
HRMS (ESI+)  
Calculated for C28H42BNNaO11: 602.2749    
Found: 602.2745  
 
O
OH
OOOMeO
O
MeN
O
OB
O
O
3.38
H2, Pd/CO
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O
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3.37  
The substrate 3.37 (230 mg, 0.40 mmol) was azeotropically dried with toluene 
under vacuum before refilled with dry nitrogen in a 40 mL I-Chem vial. 17.28 mL EtOAc 
was added followed by 10wt% Pd/C (6.36 mg/63.6 mg, 15 mol%) in one portion. 2 9-
inch full balloons of hydrogen was charged to the vigorously stirred reaction at 23 °C. 
Both balloons were recharged in 14.5 h, and in another 12 h the balloons were removed. 
The reaction mixture was passed through a pad of celite and flushed with EtOAc before 
concentration under reduced pressure. The product 3.38 which was used directly into 
the next reaction without further purification afforded crude yield 225 mg, 98%.  
 
1H NMR (499 MHz, Acetone) δ 4.25-4.18 (m, 2H), 4.12 (d, J = 16, 1H),  4.00 (d, J 
= 17.5, 1H), 3.93 (d, J = 16.5, 1H), 3.90-3.81 (m, 2H), 3.71-2.67 (m, 1H), 3.42-3.36 (m, 
1H), 3.62 (s, 3H), 3.15 (s, 3H), 1.92-1.91 (m, 2H), 1.82-1.71 (m, 6H), 1.66-1.49 (m, 14H), 
1.21-1.14 (m, 2H), 1.04-0.91 (m, 2H).   
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HRMS (ESI+)  
Calculated for C28H44BNNaO11: 604.2905   
Found: 604.2915  
 
General procedure to prepare with primary Csp3 boronates  
 
 
2-mL I-Chem vial was charged with primary Csp3 MIDA boronate 3.31 (0.145 
mmol, 1.0 equiv.), was added a solution of diol (0.434 mmol, 3.0 equiv.) in 1 mL MeOH. 
Solid NaHCO3 (0.061 g, 0.723 mmol, 5.0 equiv.) was then added.  
The reaction was stirred at 23  °C for 3 hours and then was concentrated  in vacuo 
and finely ground anhydrous CaCl2 (0.064 g, 0.579 mmol, 4 eq), solid NaHCO3 (0.024 g, 
0.289 mmol, 2 equiv.), and toluene (4.3 mL) were added to the resulting residue. The 
mixture was stirred at 23 °C for 45 minutes, filtered through a pad of celite with toluene 
(50 mL) and concentrated to yield the boronate. The product was used directly in the 
next reaction without further purification.  
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Chapter 4  
 
Third generation synthesis of BB1  
 
In Chapter 2, we discussed a successful one pot hydroboration/cross-coupling 
strategy to make the BB1-BB2 bond in a model study. This first generation synthesis 
was however hampered with the accessibility of BB1 precursor 2.63 as a consequence 
of the very sensitive nature of 2.63.  
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To address this problem, discussed in chapter 3, a very stable BB1-MIDA 3.1 was 
prepared and was readily hydrolyzed to boronic acid 3.2 for the cross-coupling. After a 
thorough screen of reaction conditions, however, a catalyst system to promote such a 
transformation was not found.  
 
 
Therefore, these studies revealed that 2.63 is unstable but reactive, while 3.1 is 
very stable yet unreactive. We hence sought for a solution that combines the merits of 
the first two syntheses. This chapter describes the successful development of a solution 
to this problem and the subsequent total synthesis of a protected form of doubly C13 
labeled AmB.  
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4.1  Third generation synthesis of BB1  
In the first generation synthesis of BB1, a route to AmB polyol subunit BB1 2.64 
in the form of 9-BBN alkyl borane was achieved and a cross-coupling of BB1 and BB2 
analog 2.65 was successfully established. Nonetheless, this approach was severely 
hampered by the instability of its intermediates such as 2.63, making a scalable 
synthesis impractical. In contrast, the second generation synthesis where BB1 was 
prepared in the form of an alkyl boronic acid employed relative stable intermediates, 
mostly in the form of MIDA boronates. However, we failed to find a high-yielding 
condition to cross-couple BB1 3.2 which was an alkyl boronic acid that is known to be 
less reactive than its alkyl borane counterpart.1 Thus, in the third generation synthesis 
we need to address both the stability and reactivity problems.  
 
Scheme 4.1.  
 
In the first generation synthesis, we discovered that ketone 2.62 is a crystalline 
white solid which proved to be more stable than most other methylene dioxane 
containing intermediates in the route. We attributed this increased stability to the 
electron withdrawing effect of the C8 ketone which reduces the nucleophilicity of the 
terminal olefin. This hypothesis also explains the physical reasons that intermediate 
2.63 which has C8 alcohol protected as electron rich TBS silyl ether, being the least 
stable compound in the route. Based on this hypothesis, we thereby prepared electron 
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deficient C8-acylated BB1 precursor 4.1. To our delight, acylation with acetic anhydride 
smoothly afforded 4.1, an intermediate which turned out to be much more stable than 
2.63. Specifically, isomerization of the terminal olefin that plagued the isolation of 2.63 
is negligible in 4.1. A highly reproducible yield for the protection was thus boosted from 
a capricious 35-71% to 82%. (Scheme 4.2)  
 
Scheme 4.2. Synthesis of acylated BB1 precursor 4.1.  
 
 
Scheme 4.3. Model cross-coupling of BB1-BB2.   
 
With a robust and scalable synthesis of C8-acylated BB1 precursor 4.1 in hand, 
we turned our attention to developing a set of conditions that would promote the boron-
selective cross-coupling of C8-acylated BB1 precursor 4.1 with the MIDA boronate 
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containing cyclic ketene acetal phosphate BB2. I was joined by fellow graduate student 
Stephen Davis for the screen of the final cross-coupling. We first attempted the model 
BB1-BB2 coupling with the same analog 4.3 that was used in our first and second 
generation syntheses. This required finding mild conditions for this cross-coupling that 
would not hydrolyze the MIDA boronate motif.2, 3 While several anhydrous basic 
conditions led to little or no product and the inclusion of bulk water led to MIDA 
boronate hydrolysis, we ultimately determined that the addition of 3 equivalents of 
water to a THF suspension of K3PO4 in the presence of the second generation SPhos 
palladacycle led to a very smooth coupling of BB1 4.1 and BB2 analog 4.3 (Scheme 
4.3).  
Concerned about potential undesired hydrolysis of BB2 MIDA boronate, fellow 
student Stephen Davis studied the rate of hydrolysis of simple MIDA boronate at 
different concentration of water and temperature. Greater than 90% of MIDA boronate 
survived with the addition of three equivalents of water at 50°C in 6 hours, which was 
enough to promote BB1-BB2 analog cross-coupling.  
Doubly C13 labeled (at C13 and C19) bifunctional building block BB2 4.5 was 
prepared by a team of my colleagues Ian Daily, Justin Struble, David Knapp, Nagarjuna 
Palyam and Jim Tucker. With both BB1 and BB2 in hand, our synthesis unfortunately 
hit another road block that cross-coupling condition from BB1-BB2 model system gave 
no product in this real BB1-BB2 coupling. Fortunately, this time only after a short 
exploration, I was able to solve the problem by running the reaction using a 
stoichiometric amount of catalyst and an elevated temperature at 70°C (Scheme 4.4).  
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Scheme 4.4. Successful cross-coupling of BB1-BB2.   
 
Collectively, these advances represent an ICC-inspired total synthesis of the C1-
C23 portion of AmB, setting the stage for ICC-based total synthesis of AmB derivatives 
having modifications in this otherwise very challenging to access portion of the natural 
product. More broadly, the success of this approach towards AmB argues very favorably 
for the effectiveness of a similar approach to other members of this family of natural 
products. Finally, the tactics and methods developed herein that proved viable in this 
very complex application, stand ready to further accelerate the development of ICC with 
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MIDA boronates as an increasingly general approach for complex small molecule 
synthesis. 
 
4.2  progress towards an ICC-based total synthesis 
of AmB-13C2  
Establishing the key cross-coupling between BB1-BB2 enabled the first step of 
our ICC-based total synthesis of AmB. Applying this platform, rapid access to the 
macrocycle was anticipated by two more cycles of deprotection/cross-coupling.  
 
Scheme 4.5. Transligation from MIDA boronate to pinacol boronate.   
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First step of the deprotection is a transligation from MIDA boronate to pinacol 
boronate 4.7, a procedure that was established by Eric Woerly and Kaitlyn Gray in our 
group (Scheme 4.5).4, 5 Interestingly, in practice instead of formation of the pinacol 
boronate, proto-deborolation to the diene was constantly observed. After lengthy 
optimization, it was discovered that this decomposition pathway was promoted residual 
palladium undetectable by 1H NMR and HPLC that was carried over from last cross-
coupling reaction. To address this drawback, two equally-effective solutions were 
developed: 1. after normal-phase column purification, treating the product with 
palladium scavenger (propylamine functionalized silica); 2. after normal-phase column 
purification, running a second reverse-phase chromatographic purification.  
Having solved this problem, collaborating with Dr. Justin Struble, we smoothly 
cross-coupled pinacol BB1-2 4.7 with bifunctional BB3 4.8 to yield the C1-C29 core of 
AmB. Upon purification, another round of deprotection-coupling followed by hydrolysis 
and macrolactonization was performed by Struble to achieve the AmB macrocycle 4.10 
with all carbon connections established (Scheme 4.6). To finish the synthesis, global 
deprotection conditions are being actively pursued in our laboratory.  
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Scheme 4.6. ICC-based synthesis of the AmB macrocycle.   
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4.3  Experimental section  
Materials.  Commercial reagents were purchased from Sigma-Aldrich, Fisher 
Scientific, Alfa Aesar, TCI America, or Frontier Scientific, and were used without further 
purification unless otherwise noted.  
Solvents were purified via passage through packed columns as described by 
Pangborn and coworkers1 (THF, Et2O, CH3CN, CH2Cl2: dry neutral alumina; hexane, 
benzene, and toluene, dry neutral alumina and Q5 reactant; DMSO, DMF: activated 
molecular sieves). All water was deionized prior to use. Diisopropylethylamine was 
freshly distilled under an atmosphere of nitrogen from CaH2.  
 
General experimental procedures.  Unless noted, all reactions were 
performed in flame-dried round bottom or modified Schlenk flasks fitted with rubber 
septa under a positive pressure of argon or nitrogen. Organic solutions were 
concentrated via rotary evaporation under reduced pressure with a bath temperature of 
23 oC unless otherwise noted. Reactions were monitored  by analytical thin layer 
chromatography (TLC) performed using the indicated solvent on E. Merck silica gel 60 
F254 plates (0.25mm).  Compounds were visualized by exposure to a UV lamp (λ = 254 
nm), and/or a solution of KMnO4 and/or a solution of p-anisaldehyde, followed by brief 
heating using a Varitemp heat gun. Column chromatography was performed using 
Merck silica gel grade 9385 60Å (230-400 mesh).  
 
Structural analysis. 1H NMR and 13C NMR spectra were recorded at 20 oC on 
Varian Unity 500, Varian Unity Inova 500NB or Varian Unity 500 instruments.  
Chemical shifts (δ) are reported in parts per million (ppm) downfield from 
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tetramethylsilane and referenced to residual protium in the NMR solvent (benzene, δ = 
7.16; CHCl3, δ = 7.26; acetone, δ = 2.05, center line; DMSO δ = 2.50, center line) or to 
added tetramethylsilane (δ = 0.00).  Data are reported as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sept = 
septet, m = multiplet, b = broad, app = apparent), coupling constant (J) in Hertz (Hz), 
and integration.  Chemical shifts (δ) for 13C NMR are reported in ppm downfield from 
tetramethylsilane and referenced to carbon resonances in the NMR solvent (benzene-d6, 
δ = 128.06, center line; CDCl3, δ = 77.0, center line; acetone-d6,  δ = 39.5, center line; 
DMSO-d6 δ = 39.52, center line). Carbons bearing boron substituents were not 
observed (quadrupolar relaxation). High resolution mass spectra (HRMS) were 
performed by Furong Sun, Elizabeth Eves and Dr. Haijun Yao at the University of 
Illinois School of Chemical Sciences Mass Spectrometry Laboratory.   
 
 
A freshly mixed solution of DMAP (136 mg, 1.02 equiv.), TEA (0.85 mL, 5.60 
equiv.)  and Ac2O (0.41 mL, 4.00 equiv.) in DCM (20 mL) was added to a solution of 
substrate (463 mg) in 5 mL DCM in a 100 mL RBF. After stirring at 23 °C for 5 h, or 
when TLC indicated full conversion, saturated aqueous NaHCO3 15 mL was added and 
layers were separated. The aqueous layer was extracted with DCM x 3. The combined 
organic layer was washed with CuSO4 twice. The CuSO4 wash was then back extracted 
with DCM. The combined organic layer was washed with NaHCO3, brine. Drying with 
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Na2SO4 was followed with concentration in vacuo. Reverse phase MPLC afforded 
product 4.1 (431 mg, 81%) as an off-white solid.  
 
1H NMR (500 MHz, Benzene) δ 5.11 (m, 1H), 4.59 (d, J = 2, 1H), 4.20-4.13 (m, 
1H), 4.16 (d, J = 2, 1H), 3.81-3.78 (m, 1H), 3.54 (m, 1H), 3.33 (s, 3H), 2.52 (dd, J = 15.5, 
7.5, 1H), 2.37-2.32 (m, 1H), 2.17( dd, 15.5, 5, 1H), 2.11-2.01 (m, 5H), 1.93-1.73 (m, 5H), 
1.69 (s, 3H), 1.64-1.47 (m, 11H), 1.18-1.11 (m, 2H).  
 
13C NMR (126 MHz, Benzene) δ 170.8, 170.0, 155.1, 128.1, 112.9, 110.9, 94.1, 74.3, 
72.1, 70.3, 67.9, 51.0, 41.5, 40.8, 39.5, 37.0, 33.2, 32.4, 31.7, 30.8, 25.8, 24.8, 24.4, 23.1, 
22.8, 20.5, 0.1.  
 
HRMS (ESI+)  
Calculated for C25H39O8: 467.2645    
Found: 467.2638   
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To a stirred 0.25 M solution of substrate 4.1 (34 mg, 73.7 µmol) in 0.3 mL THF 
was added 0.15 mL 9-BBN in THF at 23 °C . The mixture was allowed to stir for 2.5 h 
before the next step.  
In the glove box, to the solid phosphate BB2 4.5 (50 mg, 36.8 µmol) was added 
the palladium catalyst (26.5 mg, 36.8 µmol) followed by solid K3PO4 (23.5 mg, 111 
µmol), 0.2 mL THF and then above BB1-BBN 4.2 solution (approx. 0.45 mL). A 1 v% 
solution of H2O in THF (0.2 mL, 3 equiv. of H2O) was then added. The reaction was 
allowed to react for 5 h at 70 °C.  
After cooling down to 23 °C, the reaction mixture was passed through a short pad 
of florisil and flushed with EtOAc before concentration. The mixture was then loaded on 
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a florisil column with pentane. The column was then flushed with Et2O to elute the 
greasy byproduct, and the product was eluted with hex:EtOAc = 1:2.   
The product was collected as a light yellow solid, and was likely contaminated 
with leftover undetectable Pd. The solid was treated with 3 equiv. Pd scavenger (1 
mmol/g) = 2.5 x mass equiv., and dilute with hexane (50 mg/mL), after stirring at 23 °C 
for 30 min, the mixture was filtered over a pad of florisil, and flushed with EtOAc. 
Concentration gave an off-white solid.  
The solid was then treated with 3 equiv. Pd scavenger (propylamino SiO2, 2.5 
mass equiv.) in hexane, and let stir for 30 min before passing through a pad of florisil, 
flushed with EtOAc, concentration afforded pure BB1-BB2 4,6 in 67% yield (36 mg).  
 
1H NMR (500 MHz, Benzene) δ 6.86 (dd, J = 21, 10.5, 1H), 6.64 (m, 1H), 6.00-
5.96 (m, 1H), 5.62 (d, J = 17.5, 1H), 5.20 (m, 1H), 5.01 (m, 1H), 4.86 (m, 1H), 4.85-4.54 
(m, 1H), 4.44-4.28 (m, 3H), 4.25-4.24 (m, 2H), 3.95 (m, 1H), 3.89-3.86 (m, 1H), 3.78 (d, 
J = 2.5, 1H), 3.69-3.65 (m, 2H), 3.35 (s, 3H), 3.09 (m, 1H), 3.00 (m, 1H), 2.91 (dd, J = 
9.5, 2.5, 1H), 2.57 (dd, J = 15.5, 7.5, 1H), 2.44-2.23 (m, 6H), 2.13-2.03 (m, 4H), 1.99-1.84 
(m, 5H), 1.83 (s, 3H), 1.73-1.64 (m, 4H), 1.60-1.53 (m, 4H), 1.42-1.32 (m, 5H), 1.30 (s, 
3H), 1.12 (s, 9H), 1.07 (m, 1H), 1.02 (s, 9H), 1.00 (s, 9H), 0.32 (s, 3H), 0.31 (s, 3H), 0.30 
(s,3H), 0.16 (s, 3H), 0.15 (s, 3H), 0.02 (s, 9H).  
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A 40 mL vial was charged with dienyl MIDA boronate 4.6 ( 0.145 mmol, 1.0 
equiv.), pinacol (0.052 g, 0.434 mmol, 3.0 equiv.), solid NaHCO3 (0.061 g, 0.723 mmol, 
5.0 equiv.). anhydrous MeOH (3 mL) was then added. The reaction was stirred at 45 °C 
for 3 hours and then was concentrated  in vacuo and finely ground anhydrous CaCl2 
(0.064 g, 0.579 mmol, 4.0 equiv.), solid NaHCO3 (0.024 g, 0.289 mmol, 2.0 equiv.), and 
pentane (4.3 mL) were added to the resulting residue. The mixture was stirred at 23 °C 
for 45 minutes, filtered through a pad of celite with pentane (50 mL) and concentrated 
to yield 4.7 (0.143 mmol, >95%) as a white solid. The product was used directly in the 
next reaction without further purification. Note that proto-deborolation to the terminal 
diene is likely to occur is 4.6 is contaminated with 1H NMR undetectable Pd.  
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To a vial containing a stir bar and 6 mg pin ester 4.7, in the glove box was added 
I-BB3 4.8 (4.5 mg, 3.0 equiv.), Cs2CO3 (3.5 mg, 4.0 equiv.), catalyst (6.5 mg, 20%) and 
DMSO (0.2 mL). The reaction was capped and removed from the glove box and placed 
in a 35 °C heating block with stirring. In 13 h the reaction was cooled to 23 °C  and dilute 
with EtOAc and 1:1 brine:water. Layers were separated and the aqueous layer was 
extracted with EtOAc. The combined ethereal layer was washed with 1:1 brine:water. 
The solution was then dried over Na2SO4 before concentration. Chromatographic 
purification afforded the product 4.9 as a solid.  
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HRMS (ESI+)  
Calculated for C7513C2H130BN4O20Si4: 1555.8516     
Found: 1555.8512  
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Chapter 5  
 
Development of a site- and stereoreten-
tive cross-coupling of unactivated chiral 
secondary organo-boronic acids  
 
The ICC strategy for small molecule synthesis was inspired by the facile manner 
by which polypeptides are assembled from bifunctional building blocks with pre- 
formed stereochemistry and oxidation state using a single coupling reaction.1, 2 Applying 
this strategy, a number of natural products that can be retrosynthetically fragmented 
through Csp2-Csp2 connection including ratanhine,1 retinal,3 parinaric acid,3 crocacin 
C,4 peridinin,5 and synechoxanthin,6 have been synthesized in our group. 
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As discussed in chapters 2-4, the ICC approach can be extended for Csp3-Csp2 
disconnections showcased in the BB1-BB2 cross-coupling in our total synthesis of the 
AmB macrocycle. However, the system is far from general. It is evident from our 
unsuccessful second generation BB1-BB2 connection that cross-coupling of 
unactivated Csp3 organoboronic acid still remains an unsolved challenge.  
During the synthesis of BB1, I also took on the challenge of trying to find a 
solution to this “sp3 problem”. The inspiration of this project is the lead of a highly 
efficient secondary Csp3 boronic acid cross-coupling we discovered in Scheme 3.4. 
Successful development of a general solution to this problem would substantially 
increase the scope of Suzuki-Miyaura reaction, and in turn expand the scope of target 
molecules for the ICC strategy.   
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5.1   ICC strategy for small molecule synthesis  
In contrast to the synthesis of peptides,7 oligonucleotides,8 and increasingly 
oligosacharides,9 which can be rapidly and flexibly assembled in a systematic fashion 
from pre-fabricated building blocks, the synthesis of small molecules has remained a 
relatively slow, complex, and unsystematized process. With the potential of addressing 
these limitations, an analogous building block-based approach for making small 
molecules e.g. iterative cross-coupling (ICC) strategy has started to emerge. In the 
idealized limit, a collection of off-the-shelf boronic acid-based building blocks having all 
of the required functional groups pre-installed in the correct oxidation states and with 
the desired stereochemical relationships are readily assembled using only Suzuki-
Miyaura cross-coupling reaction in an iterative manner.1  
 
Figure 5.1. ICC strategy for small molecule synthesis.  
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5.2  Problems in cross-couplings of secondary Csp3 
boron center  
5.2.1  Three problems  
Iterative cross-coupling (ICC) based synthesis of a wide range of Csp2-containing 
natural products, pharmaceuticals, and organic materials has demonstrated substantial 
promise of this approach. However, at present, Csp3 boronates cannot be cross-coupled 
with the same levels of efficiency, site-, and stereoretention that is now routinely 
achieved with their Csp2 hybridized counterparts. Solving this problem stands to enable 
a wide range of stereochemically complex natural products and Csp3-rich 
pharmaceuticals to be efficiently and flexibly prepared via the simple assembly of off-
the-shelf chiral organoboronate building blocks.  
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Scheme 5.1. site- and stereoretentive cross-coupling of unactivated secondary Csp3 
boronic acid.  
 
Achieving site- and stereoretentive cross-coupling of unactivated chiral 
secondary organoboronic acids, e.g., 5.1, required concomitantly solving several major 
problems (Scheme 1), including: 1. reactivity - unactivated Csp3 boronic acids are less 
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reactive than their Csp2 and activated Csp3 counterparts, 2. site-retention - a competing 
sequence of β-hydride elimination followed by hydropalladation and reductive 
elimination from the less sterically hindered primary carbon-palladium bond typically 
generates undesired linear product 5.4 as a major byproduct, and 3. stereoretention – a 
competing sequence of β-hydride elimination followed by hydropalladation and 
reductive elimination from the more sterically hindered secondary carbon-palladium 
bond results in loss of stereochemical information pre-installed in the boronic acid.  
 
Scheme 5.2. cross-coupling of unactivated secondary Csp3 boronic acid or 
trifluoroborate salt.  
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There have been important advances in cross-coupling secondary alkyl halides. 
There have recently also been several important breakthroughs in the site- and/or 
stereo-controlled cross-coupling of a range of activated chiral secondary alkylboranes. 
However, to our knowledge, there is not a single reported example of stereo-controlled 
cross-coupling with an unactivated chiral non-racemic secondary boronic acid, e.g., 5.1 
– the simplest possible version of such a substrate.  
Examples of unactivated secondary boronic acid cross-coupling are either with 
cyclic substrate, where isomerization is impossible (equa. 5.1,10  Scheme 5.2), or 
suffer from isomerization to the linear product (equa. 5.211 and equa. 5.312). In 
addition, when substituted cyclic trifulroborate was subjected to the cross-coupling, a 
mixture of isomers through a mechanism of repeating β-hydride elimination/reinsertion 
were observed (equa. 5.413). These problems have limited the application of the 
otherwise powerful transformation of secondary Csp3 boronic acid cross-coupling. In 
fact, examples in Scheme 5.2 include all published Suzuki-Miyaura coupling of 
unactivated secondary Csp3 boronic acid or boronate to the best of my knowledge.  
Comparing to other organo-metal nucl 
Isomerization to the linear product is in fact commonly observed in the cross-
coupling of secondary Csp3 organo-metal other than boronic acids.   
 
 
5.2.2  Cross-coupling of activated secondary Csp3 boronic 
acids or boronates 
Methods have been developed to activate secondary Csp3 boron centers. These 
systems operate either by removing β-hydrogen on the substrate, making it impossible 
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for β-hydride elimination, or through a back donation to stabilize the organopalladium 
intermediate prior to reductive elimination.  
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Scheme 5.3. cross-coupling of activated secondary Csp3 boronic acid or boronate.  
 
An interesting phenomenon in the cross-coupling of activated secondary Csp3 
organoboron is the absolute stereo-outcome of the product. For instance, while cross-
coupling of enantiomerically enriched allylic pinacol borate gave product with high level 
of stereo-retention (equa 5.5,14, 15 Scheme 5.3), Suzuki-Miyaura reaction of β-amide 
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non-racemic trifulroborate salt afforded stereo-inverted product (equa. 5.616, 17). More 
interestingly, when a doubly activated allylic alpha-amide secondary Csp3 pinacol borate 
was subjected to the cross-coupling condition, the back donation of the amide would 
override the effect of the aryl group and gave stereo-inversion (equa 5.716, 18). 
Meanwhile, under otherwise identical condition, addition of an alcohol can break the 
amide-boron chelate, and provide the cross-coupled product with stereo-retention 
(equa 5.818).  
These studies on cross-coupling of activated secondary Csp3 boronic acid or 
boronate have made the first step to expand Suzuki-Miyaura reaction into a prolific area 
and to reveal the mechanistic insight for this transformation. Nonetheless, currently 
synthetic applications from these researches are limited due to functional group 
requirements for the substrate. Development of a general condition for the cross-
coupling of unactivated secondary Csp3 boronic acid would substantially improve the 
applicability of this reaction, and offer an answer to the intriguing question of the 
product stereo-outcome of cross-coupling of unactivated secondary boronic acid 
coupling.  
 
5.2.3  Catalyst screening for a solution to the reactivity and 
site-retention problems 
Developing a solution to this problem required that three challenges be solved 
simultaneously by one catalyst system, i.e., high levels of reactivity, site-retention, and 
stereoretention. To address the first two of these problems, we pursued the cross-
coupling (±)-5.1 with an aryl halide (Table 5.1). Consistent with the poor reactivity of 
secondary boronic acids, a series of standard conditions yielded no product (Table 5.1, 
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entries 1-3). Silver(I) oxide has been shown to be effective in promoting Suzuki-Miyaura 
reactions with primary alkyl boronic acids and activated secondary boronic esters.14, 19-22 
Building on this precedent, we found that the very simple combination of Pd(PPh3)4 and 
Ag2O in THF promoted the cross-coupling of 5.1 with 5.5 to generate an 81% yield of 
cross-coupling products, albeit as a 1:1 ratio of branched and linear isomers 5.6 and 5.7 
(entry 4).  
 
Table 5.1. Coupling of chiral unactivated secondary boronic acid and aryl halides. 
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Turning our attention to the problem of site-retention, we first tested ligand/Pd 
systems with the potential to accelerate the desired reductive elimination pathway. 
However, bidentate phosphine ligands23 resulted in decreased yields and/or no 
improvement in site-selectivity (Table 5.1, entries 5-7), and bulky trialkylphosphine 
ligands24 did not yield any detectable product (entries 8-10). We also sought to disfavor 
the undesired β-hydride elimination pathway by employing ligands that might block the 
required agostic interaction between Pd and a β-hydrogen on the alkyl ligand (Scheme 
5.1). Buchwald-type dialkyl biaryl phosphine ligands, which possess an ipso-interaction 
between the Pd center and the biaryl moiety on the ligand and thus could theoretically 
achieve this goal,25 are ineffective in promoting the desired cross-coupling (entries 11-
13). Along these same lines, we noted that a mechanistically analogous β-hydride 
elmination pathway that competes during C-N cross-coupling with primary alkyl amines 
was disfavored by the use of Pd(P(o-tol)3)2, in which the ortho-methyl groups on the 
ligand are proposed to sterically block the required open coordination site on Pd. 
Enouragingly, the addition of Pd(OAc)2 and P(o-tol)3 provided a 20:1 ratio of 5.6:5.7, 
albeit in modest yield. Alternative employment of preformed Pd(P(o-tol)3)2, an air-
stable and commercially available catalyst, afforded both excellent reactivity and 
virtually complete site-retention, yielding the product 3a in 81% (entry 15).  
 
5.3  Synthesis of chiral non-racemic secondary Csp3 
boronates  
In order to examine the stereo-outcome of the cross-coupling reaction, the 
starting material chiral secondary Csp3 boronic acids need to be accessed in non-
racemic forms. The synthesis of enantiomerically-enriched 2-butyl boronic acid 5.1 has 
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been reported by Brown through a 4-step process.26 However, like other secondary Csp3 
boronic acid, 2-butyl boronic acid is not stable to bench-top storage. To address the 
absolute stereo-purity and stability issue at the same time, we complexed the racemic 
boronic acid with chiral N-alkyl iminodiacedic acid ligands that were recently reported 
in our group, with the hope to provide a venue to separate the two diastereomers 
through column chromatography while forming a crystalline building block with 
excellent bench-top stability.27  
In this vein, we tested three different chiral ligands and were lucky to find that 
the two diastereomers from complexation of 2-butyl boronic acid with N-benzyl-
cyclopentyl iminodiacedic acid (BIDA) can be easily separated by flash chromatography 
to give up to 97/3 d.r.. This d.r. can be improved to 98.5/1.5 upon a single 
recrystallization. In addition, the 2-butyl BIDA boronate is stable on bench-top, open to 
air for at least 200 days; while 2-butyl boronic acid fully decomposes with 24 hours. 
Moreover, highly enantiomerically enriched (S)-5.1 can be readily prepared as the pure 
boronic acid via a simple hydrolysis of 5.8 immediately prior to a cross-coupling 
reaction.  
 
Scheme 5.4. Synthesis of chiral non-racemic 2-butyl boronic acid 5.1.  
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5.4  First site- and stereoretentive cross-coupling of 
unactivated chiral secondary boronic acid 
strategy and scope  
 With robust and practical access to (S)-5.1 in hand, we subjected this 
unactivated chiral non-racemic boronic acid to our optimized cross-coupling conditions 
and determined the stereochemical outcome via chiral GC (Scheme 3). The desired 
product 3a was formed with 88% stereoretention. 
Finally, with a high yielding, site- and stereoretentive cross-coupling method in 
hand, we performed a preliminary survey of the reaction scope (Table 2). We found that 
(S)-5.1 can also couple to activated aryl iodides (entry 1) as well as a series of non-
activated aryl bromides and iodides (entries 2-5), with good to excellent branched:linear 
ratios, and stereoretention. The reaction can be sensitive to steric hinderance on the 
oragnohalide, as no productive coupling was observed with 2-phenyl bromo- and 2-
phenyl-iodobenzene (entries 6,7). Alternatively, some electronic deactivation of the aryl 
halide is tolerable, as cross-coupling was achieved with para-t-Bu-bromobenzene (entry 
8) and even more effectively with the corresponding iodide (entry 9). A range of cyclic 
secondary boronic acids are also excellent substrates (entries 10-13). There also appears 
to be tolerance to some increased steric bulk on the boronic acid, with anti-1-methyl-
2cyclohexylboronic acid reacting with activated, unactivated, and deactivated halides 2a, 
2d, and 2i to yield the corresponding cross-coupling products13 with excellent site-
selectivity and as single diastereoisomers (entries 14-15). 
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Table 5.2. Coupling of chiral unactivated secondary boronic acid and aryl halides. The 
branch: linear ratio was determined by 1H NMR and HPLC analysis. Absolute 
stereochemistry of entry 1 and 2 were assigned by comparison with the optical rotation 
of known compound, others were assigned by analogy.   
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Table 5.2(cont’d). Coupling of chiral unactivated secondary boronic acid and aryl 
halides. 
 
In summary, we developed the first site- and stereretentive cross-couplings of 
unactivated secondary boronic acids inspired from an interesting lead we discovered 
from the total synthesis of AmB. This advance represents an important step towards 
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adding chiral secondary carbon-containing fragments to the growing list of 
substructures compatible with a general, building block-based approach for small 
molecule synthesis.  
 
5.5  Experimental section  
Materials.  Commercial reagents were purchased from Sigma-Aldrich, Fisher 
Scientific, Alfa Aesar, TCI America, or Frontier Scientific, and were used without further 
purification unless otherwise noted.  
Pd(P(o-tol)3)2, and Ag2O were purchased from Sigma-Aldrich. A gift of Pd(P(o-
tol)3)2 was donated by Johnson Matthey. Solvents were purified via passage through 
packed columns as described by Pangborn and coworkers1 (THF, Et2O, CH3CN, CH2Cl2: 
dry neutral alumina; hexane, benzene, and toluene, dry neutral alumina and Q5 reactant; 
DMSO, DMF: activated molecular sieves). All water was deionized prior to use. 
Diisopropylethylamine was freshly distilled under an atmosphere of nitrogen from CaH2.  
 
General experimental procedures.  Unless noted, all reactions were 
performed in flame-dried round bottom or modified Schlenk flasks fitted with rubber 
septa under a positive pressure of argon or nitrogen. Organic solutions were 
concentrated via rotary evaporation under reduced pressure with a bath temperature of 
23 oC unless otherwise noted. Reactions were monitored  by analytical thin layer 
chromatography (TLC) performed using the indicated solvent on E. Merck silica gel 60 
F254 plates (0.25mm).  Compounds were visualized by exposure to a UV lamp (λ = 254 
nm), and/or a solution of KMnO4 and/or a solution of p-anisaldehyde, followed by brief 
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heating using a Varitemp heat gun. Column chromatography was performed using 
Merck silica gel grade 9385 60Å (230-400 mesh).  
 
Structural analysis. 1H NMR and 13C NMR spectra were recorded at 20 oC on 
Varian Unity 500, Varian Unity Inova 500NB or Varian Unity 500 instruments.  
Chemical shifts (δ) are reported in parts per million (ppm) downfield from 
tetramethylsilane and referenced to residual protium in the NMR solvent (benzene, δ = 
7.16; CHCl3, δ = 7.26; acetone, δ = 2.05, center line; DMSO δ = 2.50, center line) or to 
added tetramethylsilane (δ = 0.00).  Data are reported as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sept = 
septet, m = multiplet, b = broad, app = apparent), coupling constant (J) in Hertz (Hz), 
and integration.  Chemical shifts (δ) for 13C NMR are reported in ppm downfield from 
tetramethylsilane and referenced to carbon resonances in the NMR solvent (benzene-d6, 
δ = 128.06, center line; CDCl3, δ = 77.0, center line; acetone-d6,  δ = 39.5, center line; 
DMSO-d6 δ = 39.52, center line). Carbons bearing boron substituents were not 
observed (quadrupolar relaxation). High resolution mass spectra (HRMS) were 
performed by Furong Sun, Elizabeth Eves and Dr. Haijun Yao at the University of 
Illinois School of Chemical Sciences Mass Spectrometry Laboratory.   
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a. Synthesis of chiral racemic MIDA boronates and boronic acids  
 
To a 40-mL sealed I-Chem vial under nitrogen was added racemic 2-butyl boronic 
acid (710 mg, 5 mmol), N-methyliminodiacetic acid (MIDA) (2200 g, 15 mmol), 
pyridinium p-toluenesulfonate (126 mg, 0.5 mmol) followed by acetonitrile (16.7 mL, 
0.3 M for the borate). The reaction was sealed and allowed to stir at 80 °C for 12 hours. 
After cooling down, the mixture was passed through a pad of silica gel before 
concentration. The light brown solid mixture was then loaded onto a silica gel column 
and flushed with copious amount of Et2O, the product was then eluted by straight EtOAc. 
Upon concentration, the product was obtained as a crystalline white solid (949 mg, 
89%).  
 
1H NMR (500 MHz, DMSO) δ 4.18 (d, J = 17.0, 1H), 4.16 (d, J = 17.0, 1H), 3.98 (d, 
J = 17.0, 2H), 2.87 (s, 3H), 1.47 (m, 1H), 1.03 (m, 1H), 0.88 (t, J = 7.5, 3H), 0.81 (d, J = 
7.0, 3H), 0.67 (s, 1H).  
 
13C NMR (126 MHz, DMSO) δ 169.1, 169.0, 62.3, 62.1, 45.4, 24.5, 13.8, 12.7.  
 
HRMS (ESI+)  
Calculated for C9H17BNO4: 214.1251  
Found: 214.1252  
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To a 40-mL sealed I-Chem vial under nitrogen was added racemic potassium 
trans-2-methylcyclohexyltrifluoro borate (1.02 g, 5 mmol), N-methyliminodiacetic acid 
(MIDA) (2.20 g, 15 mmol), pyridinium p-toluenesulfonate (126 mg, 0.5 mmol) and silica 
gel (900 mg) followed by acetonitrile (16.7 mL, 0.3 M for the borate). The reaction was 
sealed and allowed to stir at 80 °C for 12 hours. After cooling down, the mixture was 
passed through a pad of silica gel before concentration. The light brown solid mixture 
was then loaded onto a silica gel column and flushed with copious amount of Et2O, the 
product was then eluted by straight EtOAc. Upon concentration, the product was 
obtained as a crystalline white solid (1.17 g, 93%).  
 
1H NMR (499 MHz, DMSO) δ 4.17 (d, J = 17.0, 1H), 4.10 (d, J = 17.0, 1H), 3.98 (d, 
J = 17.0, 1H), 3.93 (d, J = 17.0, 1H), 2.89 (s, 3H), 1.66-1.56 (m, 4H), 1.44 (m, 1H) 1.24 (m, 
1H), 1.15 (m, 1H), 1.09-0.96 (m, 2H), 0.95 (d, J = 6.5, 3H), 0.47 (m, 1H).  
 
13C NMR (126 MHz, DMSO) δ 169.2, 168.7, 62.3, 62.0, 45.3, 36.3, 32.2, 26.5, 26.1, 
25.3, 22.7. 
 
HRMS (ESI+)  
Calculated for C12H21BNO4: 254.1564  
Found: 254.1554  
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General procedure of hydrolysis of MIDA boronate  
 
 
To a stirred solution of MIDA boronate (0.25 mmol) in 2 mL THF under argon was 
added 2 mL 1M solution of NaOH. The reaction was allowed to stir at 23 °C for 0.5 h 
before 4 mL saturated aqueous NH4Cl was added. Layers were separated and the 
aqueous layer was extracted with Et2O three times. The combined ethereal layers were 
concentrated to near dry (complete dryness might lead to decomposition) and was re-
extracted (a small portion of brine could be added if necessary) with Et2O three times 
before drying over Na2SO4 and concentrating to around 200 µL under reduced pressure. 
The solution was diluted with THF and dried with Na2SO4 again before concentration to 
a waxy solid to afford the boronic acid in quantitative yield (0.25 mmol).  
 
b. Synthesis of enantiomerically-enriched boronic acid (S)-1  
 
The preparation of benzylcyclopentyl iminodiacetic acid (BIDA) followed the 
procedure developed previously in our group.27 
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To a 40-mL sealed I-Chem vial under nitrogen was added racemic 2-butyl boronic 
acid (+/-)-5.1 (6 mmol), BIDA 5 (4 mmol), pyridinium p-toluenesulfonate (0.4 mmol) 
followed by acetonitrile (27 mL, 0.15 M for 5). The reaction was allowed to stir at 80 °C 
for 24 hours. After cooling down, the mixture was passed through a pad of florisil before 
concentration. The light brown solid mixture was then dissolved in Et2O to make a 
heterogeneous mixture and filtered; the filtrate was washed with copious amount of 
Et2O. The Et2O solution contains residual boronic acid and a ~4:1 diastereomeric ratio 
of (R)-5.8:5.8 determined for the by HPLC. The white solid was recrystalized with 
acetone:Et2O twice to give a >97% d.r. 6 (463 mg, 31%).  
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TLC: (hexanes:EtOAc = 1:1, KMnO4) 
Rf = 0.41, (S) isomer 5.8; Rf = 0.16, (R) isomer (R)-5.8  
 
1H NMR (500 MHz, DMSO-d6) δ 7.35 (m, 4H), 7.30 (m, 1H), 4.52 (d, J = 11, 1H), 
4.46 (d, J = 11, 1H), 4.13 (m, 4H), 3.93 (d, J = 17, 1H), 3.51 (q, J = 6, 1H), 2.05 (m, 1H), 
1.99 (m, 1H), 1.65 (m, 3H), 1.50 (m, 1H), 1.42 (m, 1H), 1.06 (m, 1H), 0.85 (t, J = , 3H), 
0.77 (m, 3H).  
 
13C NMR (125 MHz, DMSO-d6) δ 169.8, 168.3, 137.9, 128.3, 127.8, 127.6, 79.8, 72.1, 
70.9, 59.3, 56.4, 39.5, 29.4, 26.2, 24.9, 21.0, 14.2, 12.6.  
 
HRMS (ESI+)  
Calculated for C20H29BNO5: 374.2139  
Found: 374.2119  
 
 
To a stirred solution of 5.8 (93 mg, 0.25 mmol) in 2 mL THF under argon was 
added 2 mL 1M solution of NaOH, the reaction was allowed to stir at 23 °C for 0.5 h 
before 4 mL saturated aqueous NH4Cl was added. Layers were separated and the 
aqueous layer was extracted with Et2O three times. The combined ethereal layers were 
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concentrated to near dry (complete dryness might lead to decomposition) and was re-
extracted (a small portion of brine could be added if necessary) with Et2O three times 
before drying over Na2SO4 and concentrating to around 200 µL under reduced pressure. 
The solution was diluted with THF and dried with Na2SO4 again before concentration to 
a waxy solid to afford (S)-5.1 (25 mg, 100%).  
 
c. General procedure of coupling reactions of aryl halides with alkyl 
boronic acids 
 
In the glove box under argon atmosphere, aryl halide (0.10 mmol), boronic acid 
(0.20 mmol), Ag2O (70 mg, 0.30 mmol) and Pd(P(o-tol)3)2 (7.15 mg, 0.010 mmol) were 
taken up in THF (220 µL) in a 7 mL vial. The reaction was sealed, and stirred at 85 °C 
for 24 h. The mixture was then passed through a pad of silica gel and flushed with 
diethyl ether before concentration in vacuo. The desired product was isolated by column 
chromatography and/or preparative reverse-phase HPLC.  
 
Cross coupling reactions of aryl halides with alkyl boronic acids 
 
Product was isolated as a colorless oil (Br-, 71%; I-, 69%)  
Chapter 5 Development of a site- and stereoretentive cross-coupling of unactivated 
chiral secondary organo-boronic acids  124 
Enantiomeric ratio (Br-, 85:15, a 88% retention of e.r.; I-, 89:11, a 91% retention of 
e.r.) was determined by chiral-GC (CP chirasil-DEX CB Column)  
 
 
1H NMR (500 MHz, Benzene) δ 8.15 (d, J = 8.5, 2H), 6.96 (d, J = 8.0, 2H), 3.522 (s, 
3H), 2.33 (m, 1H), 1.37 (m, 1H), 1.02 (d, J = 7.0, 3H), 0.68 (t, J = 7.5, 3H).  
 
13C NMR (126 MHz, Benzene-d6) δ 166.8, 153.0, 130.2, 127.4, 51.5, 41.9, 31.1, 21.7, 
12.3. 
 
HRMS (EI+)  
Calculated for C12H16O2: 192.1150  
Found: 192.1141  
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Product was isolated as a colorless oil (Br-, 84%)   
 
Enantiomeric ratio (Br-, 85:15, a 88% retention of e.r.) was determined by SFC 
analysis (OD-H Column)  
 
 
1H NMR (499 MHz, Benzene) δ 7.67 (m, 3H), 7.52 (s, 1H), 7.28 (m, 2H), 7.21 (dd, J 
= 8.0, 1.5, 1H), 2.595 (m, 1H), 1.60 (m, 1H), 1.54 (m, 1H), 1.23 (d, J = 7.0, 3H), 0.80 (t, J 
= 7.5, 3H).  
 
13C NMR (126 MHz, Benzene) δ 145.1, 134.4, 132.9, 126.1, 126.0, 125.8, 125.4, 42.2, 
31.3, 22.1, 12.5. 
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HRMS (EI+)  
Calculated for C14H16: 184.1250  
Found: 184.1249  
 
 
Product was isolated as a brown solid (Br-, 75%; I-, 81%)  
 
Enantiomeric ratio (Br-, 73:27, a 75% retention of e.r.; I-, 75:25, a 77% retention of 
e.r.) was determined by chiral-GC (CP chirasil-DEX CB Column)  
 
1H NMR (500 MHz, Benzene-d6) δ 7.85 (d, J = 8.8, 2H), 6.62 (d, J = 8.6, 2H), 2.17 
(m, 1H), 1.24 (m, 2H), 0.89 (d, J = 7.0, 3H), 0.59 (t, J = 7.5, 3H).  
 
13C NMR (125 MHz, Benzene-d6) δ 216.3, 154.6, 123.7, 41.6, 30.8, 21.4, 12.1. 
 
HRMS (ESI+)  
Calculated for C10H13NO2Na: 210.1409   
Found:   210.1410  
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Product was isolated as a colorless oil (Br-, 81%; I-, 83%)  
 
Enantiomeric ratio (Br-, 92:8, a 94% retention of e.r.; I-, 92:8, a 94% retention of 
e.r.) was determined by SFC analysis (OD-H Column)  
 
 
1H NMR (500 MHz, Benzene-d6) δ 7.53 (d, J = 7.0, 2H), 7.49 (d, J = 8.0, 2H), 7.24 
(t, J = 8.2, 2H), 7.12 (d, J = 8.0, 2H), 2.48 (m, 1H), 1.53 (m, 2H), 1.19 (d, J = 7.0, 3H), 
0.81 (t, J = 7.5, 3H).  
 
13C NMR (125 MHz, Benzene-d6) δ 146.8, 141.8, 139.4, 129.0, 127.5, 127.4, 127.2, 
41.7, 31.5, 22.1, 12.5.  
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HRMS (EI+)  
Calculated for C16H18: 210.1409  
Found: 210.1414  
 
 
Product was isolated as a colorless oil (Br-, 82%)  
 
Enantiomeric ratio (Br-, 93:7, a 96% retention of e.r.) was determined by SFC 
analysis (OD-H Column)   
 
 
1H NMR (499 MHz, Benzene) δ 7.54 (M, 2H), 7.43 (t, J = 2.0, 1H), 7.38 (m, 1H), 
7.24 (t, J = 15.5, 3H),  7.06 (m, 1H), 2.50 (m, 1H), 1.55 (m, 1H), 1.49 (m, 1H), 1.19 (d, J = 
7.0, 3H), 0.80 (t, J = 7.5, 3H).  
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13C NMR (126 MHz, Benzene) δ 148.3, 142.2, 141.9, 129.2, 129.0, 127.7, 127.4, 126.5, 
126.3, 125.3, 42.2, 31.5, 22.2, 12.5. 
 
HRMS (EI+)  
Calculated for C16H18: 210.1409  
Found: 210.1410  
 
 
Product was isolated as a colorless oil (Br-, 31%; I-, 61%)  
 
1H NMR (499 MHz, Benzene) δ 7.31 (d, J = 8.5, 2H), 7.11 (d, J = 8.5, 2H), 2.49 (m, 
1H), 2.47 (m, 1H), 1.50 (m, 1H), 1.26 (s, 9H), 1.20 (d, J = 7.0, 3H), 0.81 (t, J = 7.5, 3H).  
 
13C NMR (126 MHz, Benzene) δ 148.6, 144.7, 127.1, 125.5, 41.6, 34.4, 31.6, 31.6, 
22.3, 12.5.  
 
 
 
HRMS (EI+)  
Calculated for C12H16O2: 192.1150 
Found: 192.1141  
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Product was isolated as a colorless oil (I-, 52%)  
 
Enantiomeric ratio (I-, 60:40, a 62% retention of e.r.;) was determined by chiral-
GC (CP chirasil-DEX CB Column)  
 
1H NMR (500 MHz, Benzene) δ 8.04 (d, J = 5.0, 1H), 6.85 (s, 1H), 6.35 (dd J = 5.0, 
1.5, 1H), 1.97 (m, 1H), 1.12 (m, 2H), 0.77 (d, J = 7.0, 3H), 0.53 (t, J = 7.0, 3H).  
 
13C NMR (126 MHz, Benzene) δ 150.0, 123.1, 121.2, 40.9, 30.2, 20.6, 11.9.  
 
HRMS (EI+)  
Calculated for C9H12NCl: 169.0658  
Found: 169.0656  
 
 
Product was isolated as a colorless oil (Br-, 65%)  
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1H NMR (500 MHz, Benzene) δ 8.16 (d, J = 8.5, 2H), 6.97 (d, J = 8.5, 2H), 3.53 (s, 
3H), 1.88 (td, J = 11.0, 3.0, 1H), 1.68-1.61 (m, 4H), 1.38-1.30 (m, 1H), 1.28-1.12 (m, 3H), 
0.97-0.88 (m, 1H), 0.61 (d, J = 6.5, 3H).  
 
13C NMR (126 MHz, Benzene) δ 166.8, 152.3, 130.2, 128.8, 128.1, 52.7, 51.4, 37.6, 
35.9, 35.5, 27.1, 26.9, 20.9.  
 
HRMS (EI+)  
Calculated for C15H20O2: 232.1463  
Found: 232.1466  
 
 
Product was isolated as a colorless oil (I-, 62%)  
 
1H NMR (499 MHz, Benzene) δ 7.55 (m, 1H), 7.53 (m, 1H), 7.51 (d, J = 8.5, 2H), 
7.240 (tm, J = 7.5, 2H), 7.13 (m, 3H), 2.01 (td, J = 11.0, 3.5, 1H), 1.83 (dm, J = 13.5, 1H), 
1.76-1.69 (m, 3H), 1.54-1.45 (m, 1H), 1.44-1.22 (m, 3H), 1.06-0.97(m, 1H), 0.76 (d, J = 
6.5, 3H).  
 
13C NMR (126 MHz, Benzene) δ 146.2, 141.8, 139.4, 129.0, 127.5, 127.4, 127.2, 52.5, 
38.0, 36.1, 36.0, 27.3, 27.1, 21.1.  
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HRMS (EI+)  
Calculated for C19H22: 250.1721  
Found: 250.1724  
 
d.  Determination of the absolute stereochemistry of 3a-3c  
The absolute stereochemistry of compounds 3a-3c was determined by comparison 
of the optical rotation to the literature value.28-30 All products correspond to net 
retention in the cross-coupling reaction.  
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III. Determination of benchtop stability of boronic acids and MIDA 
boronates 
The stability of 2-butyl boronic acid and 2-butyl BIDA boronates to storage as 
solids under air at 23 °C was quantified using the following general procedure: Two 7-
mL vials were charged with 10 mg of freshly prepared boronic acid or BIDA boronate at 
23 °C under ambient atmosphere. The vials containing these solid samples were then 
sealed with PTFE-lined screwcaps under ambient atmosphere and placed on the 
benchtop at 23 ºC. The solid sample present in one of the vials was then immediately 
analyzed by 1H-NMR to verify the purity and quantity of boronic acid present at time 
zero (the NMR assay is described below). After 1 day (boronic acid) or 60 days (BIDA 
boronates), the solid sample in the second vial was analyzed by 1H NMR, again by the 
method described below, to determine the quantity of boronic acid remaining at the 
indicated time. 
NMR assay: An NMR stock solution was prepared as follows: To a 25 mL 
volumetric flask was added bromoacetophenone (0.336  g, 1.69  mmol, internal 
standard  for quantification  of the boronic acid), tetramethylsilane (1  mL, internal 
standard  for the NMR shifts), and  DMSO-d6:D2O 95:5  to  a final solution volume of 
25.0  mL. To a vial containing solid boronic acid or solid BIDA boronate (see above) was 
added 1.00 mL of this NMR stock solution, and the resulting solution was analyzed by 
1H-NMR. The mmol of boronic acid or MIDA boronate present in the sample was 
determined by comparing the ratio of the integrated 4-bromoacetophenone aryl C–H 
doublets (7.90 ppm relative to TMS) to that of the boronic acid or MIDA boronate C–H 
signals.  
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